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Abstract
Alternative RNA splicing is a naturally occurring phenomenon that has been associated
with different types of cancer. Detecting splice junctions in the genome of an organism
is the key to the study of alternative splicing. RNA-Seq as a high-throughput sequencing
technology has recently opened new horizons on the studying of various fields of transcrip-
tomics, such as gene expression, chimeric events and alternative splicing.
In this research, we study prostate cancer from the viewpoint of splicing events as the
second most common cancer in North America. We have proposed a method for differ-
entially detecting splice junctions, and in a broader sense splice variants, from RNA-Seq
data. We have designed a 2-D peak finding algorithm to combine and remove the dubi-
ous junctions across different samples of our population. A scoring mechanism is used to
select junctions as features for prediction of cancer RNA-Seq data belonging to patients
diagnosed with prostate cancer against benign samples. These junctions could be proposed
as potential biomarkers for prostate cancer. We have employed support vector machines
which proved to be highly successful in prediction of prostate cancer.
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Part I
Background
1
Chapter 1
Introduction
The central dogma of molecular biology is the cornerstone of modern genetics. It consists
of two main transformations, DNA becoming RNA, and RNA becoming protein. The first
transformation is called transcription, in which from a helix-shaped double-stranded DNA
sequence, a single stranded complementary RNA sequence is produced. The resulting RNA
can be coding RNA or non-coding RNA such as rRNA, tRNA, snRNA, or lincRNA. The
second transformation is called translation, where coding RNA sequences, transcripts, make
proteins that are the main operators in a cell [34]. Between these two steps, there is also a
process that is called RNA splicing, or simply splicing. During RNA splicing, parts of the
coding gene are removed, which are called introns, and other parts are preserved, which are
called exons. Figure 1.1 which depicts RNA splicing, shows the introns with a dark color
and exons using a white color. Introns are removed and exons are retained. The points
where introns and exons are separated from each other during splicing, are called splice
junctions. The result of this process is called messenger RNA (mRNA). Messenger RNA
consists of ribonucleotides, which, in turn, code for amino acids and amino acids are the
building blocks of proteins.
2
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Splicing does not happen in the same way, all the time for the same gene. Splicing might
be altered in different ways, which would lead to the same mRNA with a slight difference
such as an included intron or a deleted exon. This process is called alternative splicing,
which has recently been shown to be more prevalent and influential in gene functions than
what was believed before. Although alternative splicing happens as a normal process in
eukaryotes, recent studies have revealed that variations in splicing patterns are associated
with some diseases such Alzheimer’s disease, and alternative splicing also regulates genes
that are associated with cancer [5; 59].
It is estimated that 95% of the multiexonic genes in humans are alternatively spliced
[43]. As such, alternative splicing explains in part the complexity of mammalians given
their small number of genes compared to other organisms [5]. It also makes the synthesis of
several different proteins from the same gene possible for higher eukaryotes [1]. Alternative
splicing has been observed using different methods, such as exon skipping which is the most
common way.
Figure 1.1: Schematic view of RNA splicing.
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1.1 Sequencing
In spite of the fact that modern DNA sequencing started in 1977 with the first complete
DNA sequence, the first sequencing of DNA happened in 1968, merely fifteen years af-
ter the discovery of the double helix [24]. Completion of the Human Genome Project in
2003 was the pinnacle in sequencing, enabling new ways to answer questions in evolution,
biology and the environment.
In genetics, the act of determining nucleic acid bases of a DNA or RNA molecule at
single base pair resolution in the correct order, is called sequencing. Many applied fields,
such as medical diagnosis, biotechnology, forensic biology and biological systems have
been revolutionized by the knowledge of DNA sequences. Obtaining complete genomes
and transcriptomes of numerous types and species of life, including the Human Genome
Project, has become possible only by modern sequencing technologies.
High-throughput sequencing, or next generation sequencing, has brought down the cost
and time of sequencing significantly during recent years. This has happened by parallelizing
the sequencing process, leading to the production of millions of sequences concurrently
[22]. Sequencing has moved from small research labs that could take months and years for
cloning and sequencing of a target gene, to the industrialized large-scale instruments, and
with the advent of next generation sequencing to the bench-top instruments in the labs.
RNA-Seq
RNA-Seq is a high-throughput sequencing technology to sequence a cDNA molecule to
retrieve genetic information regarding the sample’s RNA or transcriptome. RNA-Seq pro-
vides single-base resolution and deep coverage and can be used to measure and quantify
gene expression levels, study differentially spliced transcripts, non-coding RNAs, small
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RNAs, transcriptional structure of genes in terms of their start sites (3′ and 5′ ends), chimeric
events, gene fusion, and post-transcriptional modifications.
RNA-Seq aims to provide us with the content of mRNA. However the mRNA molecule,
in contrast to DNA, is single stranded. This property makes it unstable and hard to se-
quence, and as a result it is transformed into cDNA which is double-stranded and stable to
be sequenced.
1.2 Biomarkers in Diseases
1.2.1 Biomarkers
A biological marker, or biomarker, has been defined by the National Institutes of Health
Biomarkers Definitions Working Group as “a characteristic that is objectively measured and
evaluated as an indicator of normal biological processes, pathogenic processes, or pharma-
cologic responses to a therapeutic intervention”. Biomarkers are now widely considered as
endpoints in basic and clinical research [56]. A wide variety of events have been considered
as biomarkers previously including chimeric events and splice variants, which is the focus
of this research [5; 27].
A chimeric event happens when parts of a gene, merges with other coding sequences
of another gene that results in formation of a new gene [27]. Although this chromosomal
rearrangement process is mostly related to the development of cancer, recent studies suggest
that trans-splicing also might occur frequently in healthy cells with regulation [19]. Trans-
splicing is a chimeric event in which RNAs that have been formed separately, splice together
and form a new RNA.
Based on the observation of 3′ and 5′ splice sites at the junction of almost all of the
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chimeric RNAs in their research, Kannan et al. [27] suggested that the formation of these
chimeras has happened as a result of splicing. This finding implies the close relationship
between these two events. From a bioinformatics point of view, splicing and trans-splicing
are quite similar. The main difference in the process of their detection is that when looking
for possible splicing events, the segments of reads can not be mapped to different genes,
while the same is possible for trans-splicing.
1.2.2 Prostate Cancer
Prostate cancer is the most common cancer in North America after skin cancer, which
affects 1 out of each 6 men [55]. It is estimated that 238,000 men will be diagnosed in 2013
with prostate cancer, and 30,000 men will die because of it [55]. Adenocarcinoma is the
most common type of prostate cancer which occurs when cells lose their natural control
over growth, maturation and death.
There have been many studies regarding prostate cancer using RNA-Seq data, which
covers a wide range of applications including genome wide association and variation stud-
ies, somatic mutations, non-coding RNAs, chimeric RNA and gene fusion [15]. Feng et al.
[15] conducted an extensive survey on the most recent alternative splicing studies in cancer
using RNA-Seq data. They included a review of recently developed RNA-Seq analysis tools
and also a set of publicly available RNA-Seq datasets. Kannan et al. [27] found chimeric
RNAs using RNA-Seq data in prostate cancer [27]. They detected 27 previously-unknown
highly-recurrent chimeric RNAs.
Pflueger et al. [44] concentrated on the discovery of new gene fusions in human prostate
cancer with RNA-Seq data, and detected seven new gene fusions related to prostate cancer
including the renowned TMPRSS2-ERG. Xu et al. [68] has studied RNA-Seq data from five
CHAPTER 1. INTRODUCTION 7
prostate cancer patient and identified variations of chromosomal rearrangements, insertions
and deletions [68]. They discovered 92 human genes that had undergone somatic mutations.
Xu et al. [68] has also determined from the data that the gene TNFSF10 is unable to induce
apoptosis, and as a result it further boosts progression of abnormal tumors. Sahu et al.
[51] observed an interesting relationship between RNA splicing and prostate cancer rates
among different ethnic groups in America. In this recent study on RNA-seq enrichment of
long non-coding RNAs and alternative splicing, prostate cancer has been showed to have
a significantly lower incidence rate among Chinese population, and a significantly higher
rate among African Americans comparing to Caucasian men [51]. They also noted some
previously unknown gene fusions, among them the fusion between the genes TMPRSS2
and ERG.
Wang et al. [64] tackled the problem of discovering differentially spliced genes from
two separate RNA-Seq experiments. They designed their solution based on a negative
binomial (NB) distribution model for detection of splice junctions. They obtained their
data for the RNA-Seq library from human kidney and liver samples, but the method can
be applied to other sources, such as prostate cancer samples [64]. Prensner et al. [46] put
their focus on non-coding RNAs (ncRNAs) as emerging key molecules in human cancer.
They discovered a previously unannotated long intervening non-coding RNA (lincRNA),
PCAT-1, that is related to the progression of prostate cancer. In summary, there have been
various studies on prostate cancer recently based on RNA-Seq with the focus on chimeric
RNAs or gene fusions. These studies mostly used traditional statistical tests and focus on
biomarkers at the individual level and/or group of patients.
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1.3 Machine Learning
RNA-Seq experiments produce a vast amount of data, which requires significant compu-
tational resources in terms of time and space. Machine learning methods have proven to
be crucial for data analysis on this scale [13; 50; 69; 8]. These methods provide obvi-
ous advantages in terms of accuracy and adaptability and have been extensively used in
transcriptomics previously to study cancer [65; 48]. Feature selection, classification, and
clustering are among the significant applications of machine learning in bioinformatics.
Support vector machines (SVM) are machine learning methods which have been pro-
posed by Cortes and Vapnik [12] [62] in 1995 based on statistical learning theory, and have
since been used extensively on a wide range of applications including bioinformatics. SVM
follows a data-driven approach towards solving classification problems. High accuracy and
capacity to handle high-dimensional data such as gene expression are among the advantages
of using SVM for transcriptome analysis [53].
1.4 Motivation
The detection of biomarkers would have a meaningful impact on diagnosis and treatment
of cancer. The validity of using alternative splicing, and splice variants as a biomarker for
cancer has been widely studied [5; 54; 42; 17]. Reliable detection of splice junctions is the
most important step towards discovery of alternative splicing.
Kannan et al. [27] studied chimeric events on prostate cancer and discovered chimeras
that were only present in prostate cancer data. They also concluded that formation of these
chimeras are mediated by splicing which led us to the idea of studying differential splice
junction detection on prostate cancer. We applied our model on the same RNA-Seq dataset
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as Kannan et al. [27]. The innovative aspect of this work is based on using machine learning
and pattern recognition techniques for the purpose of classification and feature selection, as
well as data integration and processing. Our study also focuses on the discovery of splice
junctions as a feature for classification of cancer.
1.5 Problem
The problem that we have addressed in this work is finding splice junctions from RNA-
Seq data that could be proposed as biomarkers for prostate cancer. Finding a reliable and
accurate way of detecting splice junctions on an RNA-Seq dataset is the first part, and ex-
tracting meaning from junctions belonging to 30 different samples of two different classes
is the second part of the problem that we tackle in this study.
1.6 Contributions
The main contributions of this thesis are:
• Developing a model for combining and filtering out splice junctions on large scale
data using peak-finding in 2-D histograms.
• Designing a method to propose splice junctions as biomarkers based on differential
results among cancer and benign samples.
• Development of a system for prostate cancer prediction using the biomarkers and
support vector machines.
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1.7 Thesis Organization
This thesis comprises six chapters. Chapter II discusses RNA-Seq as an emerging technol-
ogy in sequencing, its advantages over previous methods and the challenges that researchers
face using it. In Chapter III, we provide an introduction to splice junctions which will be
followed up by a survey on splice junction discovery methods. Next chapter includes the
methods and materials that we have used to address our problem at hand. Chapter V in-
cludes the results of the experiments that we conducted, as well as comparisons and discus-
sions regarding them. Finally, in Chapter VI, a conclusion on this topic is made and future
works are discussed.
Chapter 2
RNA-Seq
2.1 RNA-Seq Technology
RNA-Seq has been dubbed revolutionary by the scientific community because of its ability
to transform our knowledge about eukaryotic transcriptomics at a level of detail and preci-
sion that has never been studied before [22]. Next-generation or high-throughput sequenc-
ing provides a way to sequence cDNA to study a sample’s mature RNA sequence, which
is called RNA sequencing or RNA-Seq. Next-generation sequencing supplies a ground for
massive transcript expression analysis, and has become the prominent approach to study
transcriptomics since 2008. Short reads acquired from high-throughput sequencing tech-
nologies can be used for studying transcriptome and gene structure identification. RNA-Seq
can be used for cellular phenotyping and help establishing the etiology of diseases charac-
terized by abnormal splicing patterns.
Before the invention of RNA-Seq, microarrays were the way to study the transcrip-
tome. The main methods for this purpose are hybridization-or sequence-based approaches
[66]. Limited dynamic range resulting from high level of background, saturation signals
11
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and being dependent on existing genome annotations are amongst the main restraints of
microarrays. The ability to study and measure the transcriptome without prior knowledge
of the reference genome, is one of the advantages of RNA-Seq over microarrays. This en-
ables researchers to detect previously unknown transcripts. RNA-Seq is also more sensitive
in detecting changes in low expressed transcripts [70].
Detection of chimeric transcripts and gene fusion is among many RNA sequencing
applications that are being studied extensively [27; 33; 38; 37; 45]. Chimeric RNAs have
been suggested to be a possible biomarker in at least two recent studies [49; 36]. Kannan
et al. [27] used paired read information to search for chimeric events across genome. They
looked for paired reads that could be mapped to a different gene either in the genome
or transcriptome. They used different filtering strategies to reduce the number of false
positives. The number of mismatches in the initial mapping of the reads is a criteria for this
purpose, which has been set to a tolerance rate of two mismatches.
RNA-Seq is the favorite approach to study gene expression at a base-level with high
coverage, it supplies enough reads for the purpose of detecting alternative splicing. One of
the keys to profiling this genetic information is the identification of intron-exon boundaries
or splice junctions. In RNA-Seq, the exact nature of splicing events is buried in the reads
that span intron-exon boundaries. The accurate and efficient mapping of these reads to the
reference genome over these boundaries is a major challenge, which is a requirement for
studying RNA splicing.
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2.2 RNA-Seq Preprocessing
2.2.1 Preparation
There are various technical approaches for preparation of an RNA-Seq experiment. The first
step that is common among all technology platforms is determining the amount of RNA that
is required. This amount could be different based on the sequencing platform and priming
method [67]. The majority of RNAs (>90%) existing in cells are ribosomal RNA (rRNA).
The remaining RNAs are composed of mRNA and other types of RNAs. As a result, they do
not provide useful information regarding the transcriptome. There are various techniques
to concentrate the sequencing on non-ribosomal RNAs. Selective enrichment of mRNA is
a method that can be carried out by enriching the PolyA tail present in mRNA molecules.
The resulting mRNA from the enrichment process should undergo the priming process
in the next step. This could be done using either random primers or oligo-dT primers
[15; 67], which is also called mRNA-Seq. Another consideration that should be taken into
account, especially for comprehensive RNA-Seq experiments in organisms like human and
mouse with complicated genomes, is creating double-stranded cDNA to maintain strand
specific information of the RNA [67].
2.2.2 Paired-end Reads
RNA-Seq reads comes in two types, single-end reads and paired-end reads. Paired-end
reads which are being used more and more in transcriptomic studies, consist of two frag-
ments obtained from both ends of a DNA fragment [66]. The length of an RNA-Seq read
could be up to 500bp depending on the sequencing conditions. Because of the limitations
of the technology, only sequences from the tails of that read can be obtained. In case of
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obtaining both ends of the read, it is paired-end sequencing or it is single-end if we have
only one of the reads.
Paired-end sequencing provides us with many advantages in data analysis, also it re-
quires no more DNA as single-end sequencing and hence is more efficient [25]. Using
Illumina technology, end users are able to choose their required insert size between forward
and reverse strands of DNA. A dataset of 200 million reads of 2 x 75 bp is the typical result
for a paired-end sequencing run using Illumina technology. An insert size between 120 bp
and 170 bp is generally suitable [67].
Using single-end sequencing, only one strand of the DNA fragment is sequenced and
the information from the other strand is lost. Being able to sequence the other strand, gives
us the capacity to do the aligning more accurately and reduces the number of errors.
Given the insert size of each read and position where one of the reads map to the refer-
ence genome, we know the direction and approximate position of the other read. PASSion
[70], one of the methods studied, use this information to optimize its algorithm’s perfor-
mance.
2.3 RNA-Seq Data Analysis
In RNA-Seq, bioinformatics faces similar challenges as other high-throughput sequencing
technologies. The main challenges are the development of algorithms and tools for storage,
retrieval and processing of large datasets containing the information related to millions of
short reads for each RNA-Seq run. The efficiency of these methods becomes more critical
in dealing with low abundance transcripts where the error rate becomes higher. However,
the same problem existed for previous technologies such as microarrays.
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2.3.1 Coverage
Depth of sequencing is another important aspect of any sequencing technology and also
RNA-Seq. Sequencing coverage, or the percentage of transcripts being read, is affected
by the depth of sequencing. Generally speaking, more sequencing depth will lead to higher
coverage. Sequencing depth, in turn is related directly to the cost of the experiment [26; 66].
To sequence simpler transcripts, for which alternative splicing has not been observed in
them, lower depths are sufficient. However, higher depth might be needed in specific cases,
such as when we are investigating rare events, as in lowly-expressed transcripts. The reason
is that in RNA-Seq different transcripts are expressed depending on their gene expression
levels. Also higher depth might lead to more statistically significant results.
2.3.2 Mapping
Almost in any RNA-Seq data analysis, mapping the reads is the first step to perform. RNA-
Seq is a high-throughput sequencing technology, and as such, it provides us with numerous
short reads. Depending on the details of the sequencing platform and mapping technology
being used, short reads can be mapped directly to the reference genome or can be assembled
to form contigs. These contigs can be used to reveal the transcriptome structure [66].
To maintain a high standard for the reads that are being mapped, and decrease the chance
of errors and dubious results, most of the mapping algorithms implement one or several
ways to filter out reads that have a given number of base pairs with quality scores lower than
a particular threshold. This generally also increases the speed of subsequent processing.
For large transcriptomes, as we have both a high number of reads and lengths of reads
are short, some reads may align to multiple places across the reference genome. This
alignment could have happened with different alignment scores computed by mismatches,
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deletions, and insertions. Based on the application, this problem can be addressed by dis-
carding reads that map to more than a defined number of places in the genome, or filtering
out the reads based on their corresponding alignment scores. The next step in most RNA-
Seq experiment pipelines is on selection of unique reads and removal of repeated reads.
Figure 2.1: Alignment of RNA-Seq reads across splice junctions [61]. Courtesy of User:rcogs,
Wikimedia Foundation.
Part A of Figure 2.1 illustrates the process of splicing. In Part B, the process of mapping
back RNA-Seq reads to the reference genome is shown, which leads to the detection of
splice junctions. The reads that span a splice junction are shown in a light color, and the
reads that map to a single exon are shown in black. This figure demonstrates that light-
colored reads are split when aligning back to reference genome.
Before introducing alignment solutions that are designed and developed specially to
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map short reads in higher volumes, it was only possible to map 10 million short reads using
BLAST or BLAT, which needed 6 and 43 hours to complete respectively (see Li et al. [31]).
Considering the fact that some sequencing platforms are capable of generating 200 million
reads in a single run, it could be concluded that the application of common read aligners
is not feasible with next-generation sequencing technologies. To address this issue, many
short read aligner programs such as ELAND by Mortazavi et al. [39], SOAP and SOAP2
by Li et al. [31] [32], BOWTIE by Langmead et al. [29], SMALT [70], and BWA by Li and
Durbin [30] were developed to facilitate RNA-Seq analyses.
2.4 RNA-Seq Datasets
Studies on RNA-Seq could be conducted on either real or simulated datasets. Simulated
datasets give us the ability to form reads in silico, and hence having the option to try our
methods for different environment-dependent variables such as read length and quality,
insert size, expression level, etc. Also, it provides us a reliable means to compare different
methods against each other.
Most of RNA-Seq datasets are made publicly available for further studies. Various file
formats have been proposed for storing next-generation sequencing files. Sequence Read
Archives (SRA) format is designed for storage of large amounts of sequence data, for this
reason the data is compressed and not easily read. SRA format is one of the standard
formats used by major genomic databases around the world including NCBI, EBI, and
DDBJ to store sequence data [41]. Figure 2.2 shows a paired-end RNA-Seq read in FASTQ
format from the dataset that we use in this study. Each read is represented in 4 lines in this
figure. First and third lines are read IDs, second line includes the read sequence and the
fourth line is the quality score. As can be seen, the read ID and the read length for both
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strands is the same. However, read sequence and quality scores are totally different.
The dataset that we use in our study contains more than half a million paired-end RNA-
Seq reads that have been acquired using Illumina Genome Analyzer II platform [27]. While
this dataset occupies more than 16GB when stored in SRA format, storing it in FASTQ for-
mat takes 5 times the amount of physical memory.
@SRR057653.1 HWUSI-EAS230-R:2:1:27:501 length=36
AAAAAATATGGTTAAAAACTGTATANANNANNNNNT
+SRR057653.1 HWUSI-EAS230-R:2:1:27:501 length=36
=6=@8:><)8=+-B>=:6?######!#!!#!!!!!#
@SRR057653.1 HWUSI-EAS230-R:2:1:27:501 length=36
CTTTAATACACATTAAGTCATTTAATTCTCACCTAG
+SRR057653.1 HWUSI-EAS230-R:2:1:27:501 length=36
@0=+@@@B@?>@:/@B=’><%’7>A908@<B@B==5
Figure 2.2: Sample RNA-Seq read in the FASTQ format.
Following its introduction to the scientific community, RNA-Seq has soon found its
place in research in various fields such as gene expression profiling and RNA splicing
events, and started a new era in transcriptomics. The data acquired from RNA-Seq is com-
prehensive in nature and has shaken the field of transcript identification, and has contributed
significantly to the process of transcriptome assembly. However, the challenge remains in
the bioinformatics field to develop algorithms for analyzing these data and extracting bio-
logical meaning from them.
Chapter 3
Splice Junction Detection
Detecting splice junctions has always been one of the interesting fields of studying tran-
scriptomics, and microarrays have been used extensively for this purpose in the past. Since
2008, next-generation sequencing has become the prominent method to study transcrip-
tomics. In this chapter, we present the major works dealing with the detection of splice
junctions using RNA-Seq data.
All the reviewed works have been categorized according to the method that the authors
have developed to detect splice sites. In the first category, we present the methods developed
by De Bona et al. [13], Dimon et al. [14], and Lou et al. [35]. The authors in this section
have used some sort of machine learning algorithms for detection of splice junctions in
their approach. In the second section of this literature review, we would study the methods
which try to assess the reliability of a possible splice junction by a read-counting method.
This section consists of works by Trapnell et al. [58], Wang et al. [63], Huang et al. [23].
PASSion designed by Zhang et al. [70] also belongs to this group. The third section focuses
on works that use other methods as their main way of removing false positives from their
results. These papers include those of Au et al. [3], Ameur et al. [2], and Bryant et al. [7].
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3.1 Alternative Splicing
Understanding the nature of alternative splicing is very important in the detection of splice
junctions. Figure 3.1 illustrates examples of alternative splicing. In this figure, exons and
introns are represented by rectangles and lines respectively. The most prevalent way that
alternative splicing happens is exon skipping which is shown as number 4 in the figure.
Exon skipping happens when an exon that is supposed to be part of the mRNA is removed.
Intron retention (Number 5) is the opposite, when an intron is kept in the mRNA, as it was
supposed to be removed. Alternative 3′ and 5′ splice site usage changes could also happen,
which will lead to different splicing patterns (Numbers 1 and 2). Splice sites are shown
with dark boxes in the figure. Alternative promoters and alternative poly(A) sites are also
other forms of alternative splicing [43; 5] (Numbers 6 and 7).
Figure 3.1: Different types of alternative splicing [5]. The top leftmost image shows the
normal way of splicing where introns are removed and exons are retained.Courtesy of Elsevier.
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3.2 Methods for Splice Junction Detection
RNA-Seq rose to prominence in research after 2008, and as a result, all methods of this
review have been published over a time spanning less than five years. Researchers may not
have enough time to study the works of their peers and make comparisons and experiments
on already developed methods. The works by Ameur et al. [2], Au et al. [3], and Bryant
et al. [7] which are studied in this review, have been published within a month. Obviously,
none of them had the chance to refer to each other. The interesting point is that these papers
fell into the same section in this review, which implies the similarity of their work.
3.2.1 Methods based on Machine Learning
In this section, we review the methods developed by De Bona et al. [13], Dimon et al. [14],
and Lou et al. [35]. All these methods apply some sort of machine learning technique in
their pipeline. QPALma developed by De Bona et al. [13], uses SVM and HMMSplice by
Dimon et al. [14] utilizes hidden Markov models. Lou et al. [35] use maximum likelihood
estimation in their approach to splice junction detection. Table 3.1 reviews the availability
and update frequency of these methods as software packages.
Methods based on Support Vector Machines
Short reads acquired from high-throughput sequencing technologies can be used for study-
ing the transcriptome and gene structure identification. Aligning these reads over intron/exon
boundaries is a requirement for this purpose. De Bona et al. [13] do not refer to any previous
work which relates to the subject of this review.
De Bona et al. [13] developed their approach, called QPALMA, in three independent
parts, splice site prediction model, a dynamic programming algorithm and a scoring func-
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tion. QPALMA aims to align short reads to the reference genome; splice site prediction
helps this approach to achieve better results. This part is based on a machine learning ap-
proach which uses a set of donor and acceptor sites to train a SVM predictor. The authors
propose three different extensions for the Smith-Waterman algorithm for aligning the reads
to the reference genome.
The authors state that they trained their algorithm using a simulated dataset of 10,000
previously aligned sequences. The alignment error rate for these rates has been calcu-
lated by incorporating different available pieces of information. The authors also tried their
approach on a dataset of spliced and unspliced 2.98 million reads of forward strands of
chromosome 1.
De Bona et al. [13] claim that they could align 10,000 in silico spliced reads with an
error rate of 1.78% incorporating quality information, intron length model and splice site
predictions. The authors state that it was the best rate that they could have achieved. The
authors also claim that QPALMA aligned spliced and unspliced reads with a 5.2% and 1.2%
error rates respectively.
The authors claim that they could successfully exploit all information sources to align
short reads over exon boundaries. The authors claim that their approach works reasonably
well for all next-generation sequencing platforms, including Illumina sequencing, which
has been tried in their experiment. The authors state that their method can be extended to
exploit homo-polymer errors, which is available for Roche’s 454 sequencing platform.
Method based on Hidden Markov Models
During the past decade, there has been a growing appreciation of the importance of alterna-
tive splicing as a mechanism for organisms to increase proteomic diversity and regulatory
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complexity. According to Dimon et al. [14], the ability to detect alternative splice isoforms
with accuracy and sensitivity is the key to comprehensive RNA-Seq analysis. The authors
refer to previous work by Mortazavi et al. [39], Trapnell et al. [58], Bryant et al. [7], and
Ameur et al. [2].
They note that the method developed by Mortazavi et al. [39] does not address the
question of novel junctions and cannot be used for organisms with incomplete or inaccu-
rate genome annotations. They state that the algorithm developed by Trapnell et al. [58]
performs best on mammalian transcripts with relatively high abundance, but has defects
in more compact genomes and with non-canonical junctions. They note that the method
proposed by Ameur et al. [2] has the requirement for at least one read to split evenly across
the exon-exon boundary which reduces sensitivity in low coverage datasets and transcripts.
Also, they claim that this method supports only ABI SOLiD reads.
Dimon et al. [14] state that SuperSplat, the method developed by Bryant et al. [7],
requires both pieces of a read to be exact matches to the reference sequence and conclude
that it is not robust against sequencing errors or single-nucleotide polymorphisms. The
authors claim that the algorithm designed by Au et al. [3] considers only canonical splice
junctions and requires read lengths of 50bp or greater.
Dimon et al. [14] claim that they have developed a method to avoid the inherent bias
introduced by relying upon previously defined biological information. Their algorithm,
called HMMSPlicer, works by dividing each read in two halves and seeding the read-halves
against the genome and using a Hidden Markov Model to determine the exon boundary.
They claim that both canonical and non-canonical junctions are reported and a score is
assigned to each junction, which is dependent on the strength of the alignment and the
number and quality of bases supporting the splice junction.
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The authors claim that they compared their algorithm with those designed by Trapnell
et al. [58] and Au et al. [3]. They state that they analyzed the performance of their method
on simulated reads and three publicly available experimental datasets.
Dimon et al. [14]. include the detailed results of their experiments with different al-
gorithm parameters on the examined datasets. The authors state that in comparison with
TopHat, HMMSplicer shows its ability to find more junctions with a similar level of speci-
ficity in each of the tested datasets. They state that in comparison with SpliceMap by Au
et al. [3], their method achieves 7% more matching junctions for human datasets, and it
outperforms SpliceMap in the low sequence quality A. thaliana dataset.
The authors claim that HMMSplicer combines high sensitivity with a low false posi-
tive rate, functions properly on datasets with low quality sequence reads, performs well in
datasets with uneven coverage, identifies many junctions in low abundance transcripts and
also identifies non-canonical junctions. It also finds true novel junctions in genomes with
incomplete annotation. The authors claim that their algorithm is the only software package
that provides a score for each junction, reflecting the strength of the junction prediction.
Method based on Maximum Likelihood Estimation
Studying the way that alternative splicing affects a biological system is as important as
studying its fundamental regulatory mechanisms, and as RNA-Seq provides the ability to
analyze the transcriptome in a base-level resolution and high coverage. Lou et al. [35] refer
to the work by Mortazavi et al. [39], Trapnell et al. [58], Ameur et al. [2], Au et al. [3],
Bryant et al. [7].
The authors state that the approach presented by Trapnell et al. [58] depends on the
canonical splice site motifs. They also state that as the methods developed by Ameur et al.
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[2], Au et al. [3] and Bryant et al. [7] designed based on the idea of read counting, sequenc-
ing depth can significantly affect their performance.
Lou et al. [35] proposed an approach based on maximum likelihood estimation, which
relies on geometric-tail distribution of intron lengths for aligning of paired-end RNA-Seq
reads. The authors used a package named ABMapper, which was particularly developed
for spliced mapping by the same team as the authors and is explained in Lou et al. [35].
They state that their approach is an empirical probabilistic model which adopted a two-part
distribution, an arbitrary length distribution and a geometric distribution. This method uses
maximum likelihood to estimate the most probable location for a paired-end read based on
this two-part distribution. The authors stated that their approach works in three models, one
without any a priori knowledge, and two with expression level and junction-site frequency
as a priori knowledge.
Figure 3.2: Alignment of a paired-end read by the work of Lou et al. [35]. This methodol-
ogy supports mapping of both reads across splice sites. Courtesy of Biomed Central.
The authors state that they compared their model with methods developed by Trapnell
et al. [58] and Au et al. [3]. They used two human lymphoblastoid cell-line datasets for
testing purposes. The dataset consist of 8.4 million 75 bp paired-end reads with an approx-
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imately 250 bp insert size. The results were validated with the Alternative Splicing and
Transcript Diversity (ASTD) database and the Human EST database.
Lou et al. [35] claim that their method could report 53% and 49% more splice junctions
compared to the methods by Au et al. [3] and Trapnell et al. [58]. The authors also claim
that 60% of the junctions which were predicted only by their method could be validated
by the ASTD, which comprised 22% of the total reported splice junctions. According to
the authors, this implies that the methods proposed by Au et al. [3] and Trapnell et al. [58]
missed at least one-fifth of the true splice junctions. The authors claim that by performing
an exhaustive search for junctions in the Human EST database, they found that their method
predicted splice junctions with an accuracy of 96%.
The authors claim that their proposed approach can detect 50% more splice junctions
than other existing tools. Lou et al. [35] claimed that the reason for superiority of their ap-
proach is in using first, ABMapper, which has a much higher sensitivity in spliced-mapping
than other approaches, and the second is the geometric-tail based model.
3.2.2 Counting-Based Filtering Methods
The papers reviewed in this section, use filtering methods based on counting the number
of reads covering the reference genome. The papers presented by Au et al. [3] and Ameur
et al. [2] map the reads by splitting them. The method developed by Bryant et al. [7] use
also empirical data for supporting possible junctions. The availability and update frequency
of the packages reviewed in this section are shown in Table 3.2.
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Year Author Package Name Notes
2008 De Bona et al. QPALMA
Cited by Trapnell et al. [58],
Bryant et al. [7],Wang et al. [63],
and Huang et al. [23]
Last updated in December 2010.
The package is freely available.
2010 Dimon et al. [14] HMMSplicer
Cited by Huang et al. [23],
and Zhang et al. [70]
Last updated in November 2010.
The package is freely available.
2011 Lou et al. N/A
Not Cited.
The package is not available.
Table 3.1: Availability and update frequency of the software packages mentioned in this
section.
Methods based on Mapping reads by splitting
High-throughput sequencing of mRNA opens extraordinary opportunities to identify the
spectrum of splice events in a sample on a global scale. The works presented in this section
describe the methods developed by Au et al. [3] and Ameur et al. [2] to address this problem.
Both of these methods, split the reads initially, and then try to map the fragments onto the
reference genome.
Definite fusion transcripts are commonly produced by cancer cells, and detection of
fusion transcripts is part of routine diagnostics of certain cancer types. Abnormal RNA
splicing is associated with many human diseases. For this reason, methods to identify and
quantify splicing events are important in biology and medicine. Ameur et al. [2] refer to
the work by Trapnell et al. [58].
The authors state that in the method designed by Trapnell et al. [58], a substantial num-
ber of true splice junctions, including junctions with long introns or non-canonical splice
sites are outside of the detection range, and also this method is computationally challenging
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for transcripts expressed at lower levels.
The authors state that their method consists of a combination of a split-read alignment
and the novel SplitSeek program. The alignment is performed using the AB/SOLiD whole-
transcriptome-alignment software. The method proposed by Ameur et al. [2], SplitSeek,
was developed in a way to find junction reads in which as few as five bases overlap with
the other exon. It finds exon-exon boundaries that are supported by several split reads. It is
required that each junction be covered by at least two reads with unique starting points.
The authors state that they evaluated their method using public RNA-seq data from
single mouse oocytes, which was performed on two independent samples, and consist of 50-
bp reads. They also state that they selected 22 base pairs for the anchor length according to
the highest number of uniquely mapped split reads that was obtained for this length. Ameur
et al. [2] present the results of their experiments in terms of the number of splice junctions
and insertions, number of predicted small insertions and deletions within RefSeq exons,
and number of predicted splice junctions as a function of the total number of processed
reads.
The authors claim that the exon-exon boundaries are identified almost at nucleotide
resolution and with a low false-positive rate, less than one in 10,000, for junctions within
100 kb. Ameur et al. [2] state that their method makes it possible to study splice junctions
and fusion genes while also measuring the gene expression using RNA-Seq data. They
claim, according to their results, that their proposed algorithm has a very low false-positive
rate, and they state that acquired false discovery rate of less than one for 1,000 junctions
within 1Mb and less than 1/10,000 for those within 100kb, is supporting their claim.
Au et al. [3], in their research paper, state that the method developed by Mortazavi et al.
[39] is dependent on an annotated exon library and since the exon library is incomplete,
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this method cannot find junctions that involve novel splicing events. The authors do not
mention any shortcomings of the method presented by Trapnell et al. [58].
Au et al. [3] present their method, SpliceMap, based on the idea of the mapping of
half-reads as a way to identify the approximate location of a junction. SpliceMap works in
four steps, half-read mapping, seeding selection, junction search and paired-end filtering.
It maps both halves of the read to the reference genome by a short read mapping tool.
The authors state that they compared their method with the method described by Trap-
nell et al. [58] on an RNA-Seq dataset of 23,412,226 reads. They claimed that they assessed
their method’s specificity by aligning detected junctions to human ESTs in GenBank. They
also stated that they investigated the novelty of discovered junctions by PCR experiments.
Au et al. [3] describe a comparison with ERANGE proposed by Mortazavi et al. [39]. They
also stated that they compared their method with BLAT, which is a common tool for EST
sequences alignment. The authors claimed that they calculated the performance of their
method in a specific CPU running time and compared it with TopHat by Trapnell et al.
[58].
Au et al. [3] claim that 87.9% of junctions found by their method were supported by
EST evidence. They state that SpliceMap achieves more than 95% sensitivity for highly
expressed genes, more than 90% for genes with medium expression and (40− 67%) for
genes with low expression. They state that more genes detected by SpliceMap are of higher
degree (80− 100%) of completeness in junction discovery. Au et al. [3] claim that in a
random sample experiment, 85% of novel junctions were validated using PCR experiment.
The authors stated that ERANGE found 160,899 junctions and SpliceMap found 151,317
junctions, among those found by Au et al. [3] method, 23,020 junctions, which were not
found by ERANGE, were novel. They also claimed that the BLAT package, achieved a
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similar but still slightly lower level of specificity with a much lower sensitivity (70% lower)
as compared to SpliceMap. The authors stated that it took 66 CPU hours for SpliceMap
and 12 CPU hours for ERANGE to process the data set.
They claim that based on their results, SpliceMap detects more annotated junctions than
TopHat, method presented by Trapnell et al. [58]. They claim that 50bp reads can support
an approach of direct de novo detection of splice junctions without the need to first cluster
reads to identify accepted exons, and that this approach can achieve significantly higher
sensitivity in junction detection than current leading methods of RNA-Seq analysis. They
also claim that paired-read information can help reduce false discoveries.
Year Author Package Name Notes
2010 Au et al. SpliceMap
Cited by Wang et al. [63],
Dimon et al. [14],Lou et al. [35],
and Huang et al. [23]
Last update in October 2010.
Source code is freely available.
2010 Ameur et al. SplitSeek
Cited by Dimon et al. [14],
and Lou et al. [35]
Not available for download.
Not being maintained.
2010 Bryant et al. Supersplat
Cited by Dimon et al. [14],
Lou et al. [35],Huang et al. [23]
Not available for download.
Not being maintained.
Table 3.2: Availability and update frequency of the software packages mentioned in this
section.
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Methods based on empirical RNA-Seq data
Next-generation sequencing provides a ground for massive transcript expression analysis.
RNA-Seq supplies enough reads for this purpose, and the key to profiling this genetic in-
formation is identification of intron/exon boundaries or splice junctions. Bryant et al. [7]
refer to the work by De Bona et al. [13], Trapnell et al. [58], and Filichkin et al. [16] in their
paper.
Bryant et al. [7] state that the method developed by De Bona et al. [13] relies on the
previously known splice sites for training the algorithm which influences the results. Fur-
thermore, they note that QPALMA scores junctions that conform with canonical splicing
motifs higher, so it may be inefficient in finding non-canonical splice junctions. The authors
state that this problem also applies to TopHat, the method developed by Trapnell et al. [58].
Bryant et al. [7] state that TopHat needs a high number of RNA-Seq reads to build exon
islands.
Bryant et al. [7] introduce a new approach, called Supersplat, that uses a hash table as a
way to save system memory by storing read sequences as keys and their frequencies as the
value. Supersplat uses two parameters to limit the maximum and minimum length of the
sequence. Later on, Supersplat builds location indexes based on these parameters. After
indexing the reference sequence, Supersplat identifies reads that can be aligned against
the reference genome, as possible splice junctions in an iterative process. Potential splice
junctions are filtered based on the number of overlapping reads on two intron boundaries.
The authors state that they tested the performance of their method on a set of 3,690,882
Arabidopsis thaliana reads. They used the TAIR8 database of annotated junctions to eval-
uate Supersplat’s performance. Bryant et al. [7] also state that they assessed their approach
for de novo splice junction discovery on a dataset of Brachypodium distachyon.
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The authors claim that they confirmed 91% of canonical and 86% non-canonical splice
junctions using PCR and Sanger sequencing. Bryant et al. [7] claimed that they achieved a
predicted positive rate (PPV) of 70% with the minimum read length of 6 and a 90% rate by
increasing it. According to Bryant et al. [7], this rate reaches 97% by setting the overlapping
number of reads filter to 21.
Bryant et al. [7] claim that their approach is unbiased and exhaustive, but it may generate
output files with up to tens of gigabytes in size, and the user should account for determining
the befitting criterion to filter out spurious output. The authors claim that the exhaustive
approach of their method can discover many previously unknown splice junctions.
3.2.3 Non-counting Filtering Methods
The common element between the papers presented in this section is using various filtering
techniques to omit spurious splice junctions. We tried to be as specific as possible in cat-
egorizing the papers presented in this section. As all of these methods use simple search
methods to find junctions, they need some sort of filtering to detect false positives and gain
higher sensitivity. Although, they developed methods that used various strategies for filter-
ing and also were highly similar to each other in nature. The work developed by Trapnell
et al. [58] has been categorized as a filtering based on average read depth coverage method,
the work of Wang et al. [63] as a filtering on minimum anchor length method, and the works
of Huang et al. [23] and Zhang et al. [70] as a filtering using paired-end information and
read coverage methods. The availability and update frequency of these methods is shown
in Table 3.3.
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Methods based on Filtering that use average read depth coverage
Alternative splicing is a significant process in normal cellular functions and also in human
diseases. Finding novel splice junctions is an important part of studying alternative splicing.
Trapnell et al. [58] refer to previous work by De Bona et al. [13] and Mortazavi et al. [39].
The authors mention two shortcomings of the work of De Bona et al. [13], the first is
that their method, QPALMA, depends on a set of known splice junctions from the reference
genome and cannot identify novel junctions. They state that the other shortcoming is that
De Bona et al. [13] use Vmatch, an alignment program which is not designed to map short
reads on machines with small main memories and is considerably slower than other short-
read mappers. Trapnell et al. [58] state that ERANGE, the method developed by Mortazavi
et. al, depends on available annotation of exon-exon junctions for its main objective, which
is gene expression quantification in mammalian RNA-Seq projects.
The authors introduce a new system called TopHat, which works in two phases to find
junctions. In the first phase, all reads are mapped to the reference genome using Bowtie,
all reads that do not map to the reference genome are set aside as initially unmapped reads.
Then, an initial consensus of mapped regions, called exon islands, is computed using the
assembly module in a package named Maq. Sequences flanking potential donor/acceptor
splice sites within neighboring regions are joined to form prospective splice junctions. For
each splice junction, TopHat searches the initially unmapped reads in order to find reads that
span junctions using a seed-and-extend strategy. Figure 3.3 shows the pipeline of TopHat,
that has influenced splice junction detection methods which were developed after it signif-
icantly. This figure shows different stages of splice junction discovery, including mapping
against the reference genome, generating exon islands, and mapping initially unmapped
reads to the splice sites.
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Figure 3.3: The Tophat pipeline which describes necessary steps toward detection of splice
junctions [58]. Courtesy of Oxford Journals.
Trapnell et al. [58] state that they conducted an experiment on 47,781,892 short reads
using their method, TopHat, and a previously developed method called ERANGE by Mor-
tazavi et al. [39]. The authors claim that their method could discover around 72% of splice
junctions compared to annotation-based analysis done by Mortazavi et al. [39] in fewer tran-
scribed regions and 80% of junctions in more actively transcribed regions. They claimed
that out of 19,722 newly discovered junctions that they found in their experiment, many of
them are true splices, but it is difficult to asses exactly how many of them are genuine.
Trapnell et al. [58] claim that the significance of their work is in its ability to detect
novel splice junctions. They also claimed that their tool represents a significant advance
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over previous RNA-Seq splice detection methods.
Methods based on Filtering that uses minimum anchor length
Accurate identification and quantification of transcript isoforms is crucial to characterize
alternative splicing among different cell types. In addition, sequence variants found within
splice sites or splicing enhancer sequences may have functional consequences on alternative
splicing. A large proportion of human genetic disorders results from splicing variants.Wang
et al. [63] refer to the work by De Bona et al. [13], Trapnell et al. [58] and Au et al. [3].
The authors note that the output generated by the method of Au et al. [3] does not include
tag alignments, and hence is incomplete. They do not state any shortcoming regarding the
works of others.
According to Wang et al. [63], their method operates in two phases. In the first phase,
that is called tag alignment, candidate alignments of the mRNA tags to the reference genome
are determined. A set of candidate alignments are computed for each tag as multiple possi-
ble alignments may be found for each read, which is shown in details in Figure 3.4. Map-
Splice uses a double-anchor search method to look for the splice junction. In the second
phase which is called splice inference phase, splice junctions that appear in the alignments
of one or more tags are analyzed to determine a splice significance score based on the qual-
ity and diversity of alignments that include the splice. The most likely alignment for each
tag is chosen based on the splice significance score.
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Figure 3.4: Mapping of a read across two splice junctions by MapSplice [63]. Courtesy of
Oxford Journals.
The authors state that they evaluated specificity and sensitivity of their method using
an experiment on a generated synthetic dataset. They also state that they validated their
method using quantitative RT-PCR experiment. Wang et al. [63] state that they achieved
a true-positive rate of 96% and false-positive rate of 8% for their method. They stated
that over 77% of canonical junctions found by their method were confirmed by known
transcripts in GenBank, which was between 6% to 11% higher in comparison by TopHat
method by Trapnell et al. [58].
The authors claim that both TopHat by Trapnell et al. [58] and their method were more
memory efficient and much faster in experiments than SpliceMap by Au et al. [3]. They also
claim that their method performed best by detecting more true-positive junctions and fewer
false-positive junctions than the other two methods. They state that longer tags improve
both the sensitivity and the specificity of the junction discovery in their method and as well
in the method by Trapnell et al. [58]. They claim that in comparison, their method has a
higher sensitivity in different tag lengths. They also claim that using read lengths of 75 or
100bp yields significantly better sensitivity and specificity for splice detection.
Methods based on Filtering that use paired-end information and read coverage
Splice junction detection is the first step of studying alternative splicing. Alternative splic-
ing is highly effective on diversity of proteins, as it causes different mRNAs to be pro-
duced from the same gene. These different mRNAs translate into different protein isoforms.
Huang et al. [23] refer to the previous work by Mortazavi et al. [39], De Bona et al. [13],
Trapnell et al. [58], Bryant et al. [7], Au et al. [3], Wang et al. [63], and Dimon et al. [14].
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The authors state that QPALMA, the method developed by De Bona et al. [13] which
uses a machine learning approach, is biased toward splice junctions that are similar to the
ones in the training data set. Huang et al. [23] state that low sequencing depth affects the
performance of the algorithm developed by Trapnell et al. [58] and hence there would not be
enough reads for efficient junction detection. The authors state that the method introduced
by Bryant et al. [7], which uses hashing as its alignment approach, needs a large amount of
memory and computing power and as a result is not scalable for reads longer than 50 base
pairs.
Huang et al. [23] state that SpliceMap, the algorithm presented by Au et al. [3], per-
forms poorly when dealing with the reads that can be mapped to more than one location.
Furthermore, they state that this approach is not efficient when the transcriptome is lowly
expressed or the reads have sequencing errors. The authors state that the method developed
by Wang et al. [63] has some inefficiencies while the sequencing depth is low, which leads
to a reduced call rate. The call rate is the number of true positives divided by total number
of junctions.
Huang et al. [23] present SOAPsplice, which finds the splice junctions in two steps.
In the first step, it maps the reads onto the reference genome using the Burrows Wheeler
Transformation for indexing. Then, SOAPSplice detects splice junction candidates based
upon some criteria, which include following known splicing motifs and a maximum in-
tron size of 50,000 bp. SOAPsplice applies two different filtering techniques to omit false
positives. The first strategy is to check the paired-end information with the direction of
the mate-pair reads and later discarding incompatible junctions. The other strategy is to
filter out the junctions that have a missing segment between two sub-reads that have been
mapped to the reference genome.
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Huang et al. [23] compared their method with the algorithms developed by Trapnell
et al. [58], Wang et al. [63], and Au et al. [3] on two 50 and 150 bp simulated datasets and
two 51 and 130 bp real datasets.
The authors claim that based on the results of the simulated datasets for both 50 and 150
bp length reads, their method had the highest call rate while it kept the false positive rate at
its lowest compared to other approaches. For the real dataset with 51 bp reads, Huang et al.
[23] claim that SOAPsplice detects more novel junctions than TopHat by Trapnell et al. [58]
and its results are comparable to the method designed by Au et al. [3] on both novel and
known junctions. According to the authors’ claim, SOAPsplice found more splice junc-
tions than the other compared methods, and 97.24% of detected junctions were reported
by more than one method. Huang et al. [23] claim that although their method found fewer
novel junctions than the methods by Au et al. [3] and Wang et al. [63], but the percentage
of junctions that are reported by more than one method for SOAPsplice (85.34%) is sig-
nificantly higher than those of the other algorithms (TopHat: 67.73%, SpliceMap: 63.24%,
MapSplice: 77.54%).
Huang et al. [23] claim that their method is more efficient for detecting novel splice
junctions as it outperforms all other algorithms with various read lengths and read depths,
especially when sequencing depth is lowest. This is very important considering that new
junctions are usually found in low abundance parts of the transcript. The authors claim that
their method is able to detect more genuine splice junctions than the compared methods.
As described by Zhang et al. [70], RNA-Seq can be used for “cellular phenotyping” and
to help establish the etiology of diseases characterized by abnormal splicing patterns. Re-
cent studies have revealed that variations in splicing patterns are associated with Alzheimer’s
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Year Author Package Name Notes
2009 Trapnell et al. TopHat
Been cited by all papers,
that reviewed in this study,
which published after it.
The most cited paper in overall.
The package is being updated
very often and source code is
freely available.
2010 Wang et al. MapSplice
Cited by Huang et al. [23],
and Zhang et al. [70]
The package is being updated
regularly and source code is
freely available.
2011 Huang et al. SOAPsplice
The package is being updated
regularly and the package
is freely available.
2012 Zhang et al. PASSion
The latest published package
reviewed in this study.
Source code is freely available.
Table 3.3: Availability and update frequency of the software packages mentioned in this
section.
and other complex diseases. In RNA-Seq, the exact nature of splicing events is buried in the
reads that span exon-exon boundaries. The accurate and efficient mapping of these reads to
the reference genome is a major challenge.
Zhang et al. [70] refer to previous works by Trapnell et al. [58], Dimon et al. [14], and
Wang et al. [63]. The authors claim that the methods developed by these authors do not
have the ability to detect junctions without known splicing motifs. Zhang et al. [70] state
that both HMMSplicer by Dimon et al. [14] and MapSplice by Wang et al. [63] potentially
work better for long reads than for short reads and they are less accurate on highly abundant
transcripts. They also claim that neither of these two methods exploit the paired informa-
tion in their algorithms.
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Figure 3.5: First step in PASSion pipeline, including mapping the reads using SMALT and
creating exon islands [70]. Courtesy of Oxford Journals.
PASSion finds the splice junctions in five stages including the initial mapping, build-
ing exon islands, high-resolution remapping, filtering and detection of canonical and non-
canonical junctions. As shown in Figure 3.5, exon islands are built by piling up the mapped
reads after initial mapping by a fast aligner. Pairs of one exonic read and one unmapped read
are used as the basis of junction identification. These pairs are remapped, using the pattern
growth algorithm, to the reference genome and a splice junction is reported if the unique
substrings from both ends can reconstruct the original split read and has a sufficiently large
number of supportive reads. Figure 3.6 shows this process in detail.
Initial mapping and high-resolution remapping are the most time-consuming parts of
the PASSion’s pipeline. PASSion uses SMALT for the initial mapping of the reads to the
reference genome. SMALT is an aligner that has been designed by the Sanger Institute [70],
for aligning of DNA sequences to the reference genome. It only accepts sequence input data
in FASTA or FASTQ format. SMALT uses a hash index of short sequences under 21 base
pairs long.
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Figure 3.6: Using paired-end sequencing technology in splice junction discovery in PAS-
Sion. PASSion designates a mapped read with an unmapped pair as anchor, then uses the
direction of the anchor to look for the other pair possibly mapped across a splice junction
[70]. Courtesy of Oxford Journals.
Zhang et al. [70] analyzed their method on both simulated and real data. They compared
the performance of PASSion with those of TopHat by Trapnell et al. [58], MapSplice by
Wang et al. [63] and HMMSplicer by Dimon et al. [14] on these datasets. The authors claim
that on simulated data, their method, alongside other three tested methods, can detect almost
all the true junctions when coverage is > 100×fold. They note that PASSion predicted
136,664 and 172,568 splicing events for the two real datasets, of which 84.1% and 80.3%
are known junctions.
Zhang et al. [70] state that on the short read library of simulated data, the method by
Trapnell et al. [58] showed the least sensitivity comparing to other methods, and on libraries
with long reads, MapSplice by Wang et al. [63] detects the lowest number of junctions. The
authors claim that in all simulated datasets, the true positive rate of PASSion has the quick-
est growth rate along with the read coverage and it is the most sensitive method overall.
Zhang et al. [70] state that when the specificity of TopHat, MapSplice and HMMSplicer
drops with the read coverage, PASSion’s specificity remains high with specificities of more
than 97%.
The authors claim that for real datasets, in general, PASSion displays a balanced per-
formance with both a high number of predictions and high confirmed ratios. They state that
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the pattern growth algorithm, which is used in their approach, has not been taken advantage
of in RNA-Seq analysis before. Zhang et al. [70] note that PASSion can detect junctions
with unknown motifs, which other three methods were unable to do so. Zhang et al. [70]
state that their method had missed some rare cross-chromosome splicing events, because it
has been assumed that two reads map to the same chromosome. They suggested working
to resolve this issue in the future.
3.3 Conclusion
The work of Trapnell et al. [58] has been cited by 8 out of 10 papers that had been included
in our review of splice junction detection methods. This means that except the work of De
Bona et al. [13] that has been published prior to their work, all subsequent works on this
subject referred to it. Furthermore, the method developed by Trapnell et al. [58], was used
by all other methods as a basis for evaluating the performance of their own work. Table 3.4
lists the works studied in this chapter, and reviews their major contributions.
De Bona et al. [13] state that their method can be extended to exploit homo-polymer
errors, which is available for Roche’s 454 sequencing platform. Trapnell et al. [58] suggest
that using paired-end reads will drastically reduce the number of false positives in TopHat,
and also improves its performance.
Au et al. [3], Lou et al. [35], and Zhang et al. [70] developed their methods to exploit
paired-end read information. Huang et al. [23] mention that in the future, their method
could be optimized to run faster and consume less memory. We observed that SOAPSplice,
the method presented by Huang et al. [23], has been updated after publishing the paper to
reduce the amount of memory usage while generating the output.
Based on the studies on advantages and disadvantageous of various methods on splice
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junctions discovery over each other, we chose to apply PASSion designed by Zhang et al.
[70] in our study. The advantage of PASSion is that it had been originally designed to
exploit paired-end information which is used in its mapping algorithm. Also the work by
Zhang et al. [70] was the latest method developed on this topic studied in our review. There-
fore, they had the chance to compare their results against previously developed methods.
PASSion uses only known splicing motifs in the last step in its pipeline to finalize the break-
point of a junction. As PASSion does not use known motifs in detecting junctions, it can
detect junctions with unknown motifs.
Overall, PASSion showed a very high rate of accuracy in both high and low abundant
transcripts [70]. The only downside of using PASSion is that under the same conditions, it
consumes between two to four times more memory than the methods developed by Trapnell
et al. [58], Dimon et al. [14], and Wang et al. [63]. Also, PASSion is the second slowest
method among other methods in terms of CPU time.
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Year Author Title of Paper Major Contribution
2008 De Bona et al.
Optimal spliced alignments of
short sequence reads.
QPALMA, one of the first
works to address splice junction
finding on RNA-Seq data.
Use of SVM to find
splice junctions.
2009 Trapnell et al.
TopHat: discovering splice junctions
with RNA-Seq.
Introduces the concept
of anchor as a way.
Presents the idea of generating
exon coverage islands.
2010 Au et al.
Detection of splice junctions
from paired-end RNA-seq
data by SpliceMap.
Designed to use information
of paired-end reads.
First method to use
half-read mapping.
Use of hash table for mapping.
2010 Ameur et al.
Global and unbiased detection
of splice junctions
from RNA-seq data.
SplitSeek, splits reads to two
fragments and map them
independently as anchors.
2010 Bryant et al.
Supersplat–
spliced RNA-seq alignment.
Employs empirical RNA-Seq data
for splice junction detection.
2010 Wang et al.
MapSplice: accurate mapping
of RNA-seq reads for splice
junction discovery.
Defining minimum anchor
length as a filtering strategy.
Comprehensive experiments on
effect of various criteria
including noise.
2010 Dimon et al. [14]
HMMSplicer: a tool for efficient
and sensitive discovery of
known and novel splice junctions
in RNA-Seq data.
Employs hidden Markov model
to determine the exon boundaries.
2011 Huang et al.
SOAPsplice: Genome-Wide
ab initio Detection of Splice
Junctions from RNA-Seq Data.
Claims to achieve a better
performance than other major
methods using more Memory
and more computing power.
2011 Lou et al.
Detection of splicing events
and multiread locations from
RNA-seq data based on a
geometric-tail (GT) distribution
of intron length
Incorporates MLE method
to align paired-end reads
into reference genome.
Introduces geometric-tail
distribution for intron lengths.
2012 Zhang et al.
PASSion: A Pattern Growth
Algorithm Based Pipeline
for Splice Junction Detection
in Paired-end RNA-Seq Data.
Introduces Pattern Growth
algorithm to remap the reads.
The ability to identify
junctions with unknown
splicing motifs.
Table 3.4: Splice junction discovery tools at a glance.
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Chapter 4
Methods
In this chapter, we discuss the proposed methodology of our approach to the problem of
finding biomarkers in detail. As Figure 4.1 illustrates an overview of the pipeline of the
proposed method, we start by describing the details of the dataset that we have used and the
pre-processing that enable for splice junction detection. As PASSion’s algorithm has been
discussed in the previous chapter, here we describe its parameters and details of operation
for our study. Following the way, we come across the specifics of our algorithm used for
filtering splice junctions, and selecting and proposing them as biomarkers and classification
features. At last, we introduce SVM as our machine learning method of choice for the
classification of the samples belonging to cancer and normal classes. Also, k-fold cross-
validation is incorporated to validate the accuracy of our predictions.
4.1 Dataset
We have used a dataset consisting of raw RNA-Seq data belonging to 20 samples belonging
to patients diagnosed with prostate adenocarcinoma and 10 matched benign prostate tissue
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samples as our control population. None of the patients had received any preoperative
therapy prior to radical prostatectomy. This dataset is publicly available as a GEO dataset
with the Accession number GSE22260 [27].
The dataset contains more than 667 million paired-end RNA-Seq reads that have been
acquired using the Illumina Genome Analyzer II platform. It includes 30 files in SRA
format for 30 different samples. The dataset consists of short reads with of length 36 base
pairs for both forward and reverse strands. Also, the insert size for the prostate cancer
dataset is 150 bp.
4.1.1 Input data format
FASTA is one of the most well-known file formats used to represent and store nucleotide
sequences, in which they are depicted by a sequence of characters. This text-based format
is one of the formats that major databases such as NCBI accept as the input method to
query their databases. Each read sequence in FASTA format contains a line of sequence
description followed by the sequence itself. Different databases use their own template for
the sequence description line to specify the format based on their needs.
FASTQ format is the successor of FASTA format that completes it by including the
quality information for each read in the file. FASTQ has become the de facto standard for
storing high-throughput sequencing technologies.
Most of the well-known software packages, as well as all packages that we use in this
study, are only compatible with FASTA/FASTQ format. For this reason, we used SRA-
Toolkit, developed by NCBI, to convert our dataset in SRA format to FASTQ format [41].
As SRA format stores both strands for reads in a single file, we needed to split each SRA
file belonging to a sample into two separate FASTQ files to account for paired-end input
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format of PASSion. We used “split-3” as a parameter in SRA-Toolkit in order to obtain the
FASTQ files in paired-end format.
Figure 4.1: Pipeline for proposed model of this study.
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4.2 Splice Junction Detection
The splice junction detection module is shown in details in Figure 4.2. In the following, we
describe each part of this pipeline separately.
Figure 4.2: Splice junction detection pipeline.
4.2.1 Reference Genome
In order to successfully run PASSion, SMALT and SAMTools packages should be installed
on the system as PASSion employs them in its pipeline. SMALT is a fast read aligner
developed by the Wellcome Trust Sanger Institute which utilizes a hash index of short
words in its algorithm. SMALT accepts reads and the reference genome in FASTA or
FASTQ format. Prior to running PASSion, chromosome IDs used in the reference genome
should be indexed separately by SAMTools. The resulting index file is used by PASSion as
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an input. We used the latest version of the Human Genome, Build 37 (GRCh37.p10) from
the Genome Reference Consortium [11], as our reference genome which acted as an input
for PASSion and SAMTools. All mentioned software packages have been designed solely
for Linux, and are publicly available.
4.2.2 PASSion
PASSion accepts five required and multiple optional arguments as input parameters. The
required parameters are insert size, the paths to the two input read files, the reference se-
quence, the reference sequence index by SMALT. All optional arguments has been set to
their default values recommended by Zhang et al. [70]. One of the important parameters,
the cut-off limit, which is described in the following, has been set to 0.1. This parameter
implies that any junction where its cut-off score falls short of the this limit will be discarded.
cut−o f f junction = number o f support readscoverage o f higher expressed f lanking exon (4.1)
Other important parameters include maximum number of SNPs allowed that is set to
two. Minimum intron size has been set to 20, and sequence error rate is fixed at 0.05.
Detail output file
PASSion includes details about the mapping of the split reads across each exon-exon junc-
tions in a file called Junctions.detail. A sample Detail file is depicted in Figure 4.3.
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####################################################################################################
1544 D 615 ChrID gi|224384768|gb|CM000663.1| BP 21807470 21808086 BP_range 21807470 21808091
Supports 1 + 0 - 1 S1 2 S2 18.123 LL 16 RL 20 SUM_MS 36 NumSupSamples 1 - 1
ACCAAGAAGAGGAAGAAGACCAAGGCCCACCATGCCccaggtaagt<595>ttctacttttCCAGGCTCAGC
CAAGGCCCACCATGCC CCAGGCTCAGCAGAGAGCTG -21808102
36 -@SRR057629.2921017_1
Figure 4.3: Sample Junction.detail PASSion output file.
BED output file
PASSion stores the found splice junctions using the BED format. The BED format sup-
plies the means to store data for an annotation track as standardized by the UCSC genome
browser [6]. This format requires three fields as obligatory and nine fields as optional.
The required fields store chromosome name, the starting position of the desired feature in
chromosome, and ending position of that feature. Other fields could include information
such as line name, score, strand direction, RGB value, block start and end, and block count.
PASSion uses mainly chromosome start and end field to store break point ranges for each
junction. According to Zhang et al. [70] starting and ending position of a junction can be
calculated using the following equations:
Junctionstart position = chromosome start position+block start (4.2)
Junctionend position = chromosome end position−block end +1 (4.3)
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gi|224384768|gb|CM000663.1| 21807454 21808105 JUNC_0 1 . 21807470 21808091 255,0,0 2 16,20 0,631
gi|224384768|gb|CM000663.1| 94953327 94953469 JUNC_1 3 . 94953345 94953449 255,0,0 2 18,24 0,118
gi|224384768|gb|CM000663.1| 53543454 53544066 JUNC_2 6 . 53543471 53544038 255,0,0 2 17,31 0,581
Figure 4.4: Sample Junction.bed PASSion output file.
PASSion saves block coordinates as the 11th field of the BED file, in which block start
and end coordinates are separated by a comma. As an example, for the first read of the
sample BED file in Figure 4.4, junction start position can be calculated as Junctionstart :
21807454+16 = 21807470 and Junctionend : 21808105−20+1 = 21808086.
These starting and ending positions match the positions for the same read in the corre-
sponding detail file after the phrase “BP” (Break-point), which is shown in Figure 4.3. The
number 1 after the phrase “Supports”, in the detail file, indicates that there is only one read
supporting this junction. This means that the expression level for this junction is only one.
This measurement number can also be found after the junction ID in the bed file (Figure
4.4).
4.3 Filtering Junctions
As we introduced 30 different samples which were processed separately by PASSion in our
system, it was conceivable that PASSion could not account for the factor of error set forth by
differential analysis of the input data. Our dataset included 20 samples in the cancer class
and 10 samples in the benign class in total. Due to this low number of samples and also the
high probability of base pair errors in the mapping process, we needed to identify the same
junctions across all different samples with high accuracy. That is necessary as a single base
pair error introduced in mapping, in either the starting position or the ending position of a
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junction, could jeopardize the process for that junction. We developed a method to filter out
dubious junctions to improve the accuracy of our method as well as to decrease the error
rate. Different parts of our approach for addressing this issue are illustrated in Figure 4.5.
This problem can be modeled as a peak-finding problem in a 3-dimensional space.
Figure 4.5: Modules for filtering junctions.
The solution to the problem of finding splice junctions as biomarker for cancer samples
is based on alternative splicing, which means that in some samples that have been affected
by cancer, mRNA has been spliced differently than the normal samples. We designed a fast
and efficient algorithm to account for the inherent differences that have been introduced to
the system by running peak finding separately for starting and ending positions.
CHAPTER 4. METHODS 54
Considering the fact that starting and ending positions of each junction are the bound-
aries between exons and introns, we expect in case of alternative splicing in each sample the
same position would happen in other junctions but with different starting or ending posi-
tions. It is important to remember that studying alternative splicing only is possible because
we are mapping our reads against the reference genome. Our method models the starting
and the ending points as semi-independent entities to each other.
4.3.1 JunctionResolver
We developed a Java API called JunctionResolver to handle all processing involved in
working with junctions. The Junction class contains the following fields: start, end, length,
expLvl, chrom corresponding respectively to start and end position of a junction relative
to the chromosome, length of the junction, number of reads supporting the junction, and
chromosome ID of the junctions. Chromosome ID for chromosomes 1 to 22 are the same
as their number, and we considered 23 and 24 for X and Y chromosomes for convenience.
A class called ChromJunc were designed to store a list of junctions belonging to each
specific chromosome. Classes BedReader and DetailReader have been developed to read
information from PASSion’s output files. In order to differentiate between samples, we in-
cluded the sample ID as a property in the BedReader class. We developed the ChromFinder
class in order to find each junction in a list of junctions, which are stored as a ChromJunc
object. A class named Comparator has been designed to compare junctions for two dif-
ferent ChromJunc objects and report the number of junctions that start or end at the same
position.
We developed a solution to write data in Comma-separated values (CSV) format to store
data for the next module of our pipeline. Figure 4.6 shows a sample of the output of the
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JunctionResolver module in CSV format. This file includes the sample ID, the chromo-
some ID, starting position, ending position, junction’s length, and supporting reads count,
respectively for each junction.
29,1,21807470,21808086,616,1
29,1,94953345,94953446,101,3
29,1,53543471,53544036,565,6
Figure 4.6: Sample CSV output file.
4.3.2 Merging Chromosomes
As starting and ending positions of the junctions are relative to each chromosome, it was
critical for our program to separate the junctions by chromosomes. As the first step, we
used MATLAB to read CSV files belonging to each sample based on the sample ID in their
file names, also CSV files included the sample ID as the first field for each junction. We
separated the junctions for each chromosome in a different data structure. After this step,
we would have a table with the size of number o f chromsomes×number o f samples cells.
This table in our case included 24× 30 cells. This table will be the input for our peak
finding module as described in Algorithm 1. In the next step, we join all junctions for each
chromosome in a single cell. The results will be a table of 1× number o f chromosomes
cells.
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4.3.3 2-D Peak finding
We designed a module in MATLAB to create a histogram based on either starting or ending
position of junctions, and this module was utilized on all chromosomes. The last position
of a starting junction on the first chromosome was 249,231,781 in our dataset. To account
for the amount of memory required to process the data for the whole genome in this scale,
we used the sparse matrix data structure in MATLAB to handle the problems arising from
working with these huge tables. The solution was to split the table into several smaller
windows, transform the data into a full matrix for each of them, and then process the data
in each window separately. Finally, we merge the results together in a new sparse matrix
structure. The size of the window is a parameter for our module that has been set to 100,000
for our study.
We also implemented a safety mechanism to make sure that no peak occurs at the bound-
aries of a window. In order to do so, in case of a non-zero value at vicinity of a window,
we move the window until we reach an empty space with at least a length of 5. We have
developed a module, that uses MATLAB to find the rough peaks, to find junctions along
the whole chromosome using the sparse matrix as described.
We define a parameter called margin to be passed to this module as a minimum peak
distance variable, which defines the minimum distance between two peaks. After peak find-
ing process on starting positions finishes, if position a is found as a peak, we search for all
junctions that have a start position in the neighbourhood of (a−margin,a+margin) and we
acquire a set of ending points for the selected starting points. As our peak finding module
discards some starting points near peaks, we use our margin parameter to account for them
when analyzing end points in the next step. Considering the minimum length of a junction
in our dataset which is 19bp , we selected 5bp as the vicinity for combining junctions. This
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gives a safe margin near a quarter of the size of the minimum intron. We chose margin= 2
to cover a 5bp area of the genome for each junction position.
Data: Junctions table of size samples× chromosomes
Result: Set of merged junctions per chromosome
direction← “start”;
margin← 2;
for k← 1 to Number of chromosomes do
Positions(k)←CombineSamples(k,direction);
Peaks(k)← f indPeaks(Positions(k),margin);
foreach start position i of the Peaks(k) do
for j← i−margin to i+margin do
endPositions( j)← End points f or all junctions starting on j;
end
endPositions(i)← f indPeaks(endPositions( j),margin);
end
end
Algorithm 1: 2-d peak finding algorithm.
Ending points
So far, we have unified the starting points for all junctions in each chromosome across all
samples. As can be seen in Algorithm 1, these unified starting points have been found by
running peak finding modules for the first time. We continue by considering each starting
point separately i of Peaks(k). For each starting point, only end points are deemed fit that
have their starting position in the vicinity of our unified starting positions, and hence these
points act as a mean to limit the searching space to find the local maxima. To obtain the
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final junctions, we run our peak finding algorithm on the ending points. We also stored
sample IDs for each ending point of a junction.
4.4 Selecting Junctions
4.4.1 Scoring Junctions
We propose a method to score each junction based on the number and class of samples
which that junction occurs in them. Given the fact that we have twice the number of cancer
samples compared to our benign population, our model considers a +1 score for each sam-
ple that belongs to the cancer class, and a −2 score for each normal sample. The scoring
formula is defined in Equation 4.4. This scoring scheme guarantees that a junction that has
occurred in all samples, which implies no significance in terms of differentiating between
classes, would receive a score of zero.
Score junction = (No. o f JunctionsNormal×−2)+(No. o f JunctionsCancer×1) (4.4)
4.4.2 Thresholding
We can limit the number of junctions reported by our filtering mechanism based on a de-
fined minimum score. As high scoring junctions have occurred more frequently in only one
class of our samples, they are expected to be more significant as features for a classification
scheme.
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4.4.3 Expression Level Measurement
The number of reads supporting each junction could act as a measure on the importance
and impact of a particular junction across different samples. We exploit this information by
creating a table of expression levels for each junction across all samples, which has scored
higher than our score thresholds. We use this table as the feature set for our classification.
Figure 4.7 shows a sample of this table containing expression level measures on three lines
for three different junctions. The first 20 numbers on each line correspond to the expression
measure for samples belonging to the cancer group and the remaining 10 numbers are ex-
pression measures for the samples in the benign group. A value of 0 for any sample implies
that the specific junction has not been found for him, and any value greater than 0 shows
the supporting number of reads for that junction.
0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,2,0,1,0,2
3,1,19,4,37,8,3,9,14,16,0,27,23,10,57,7,53,30,1,16,0,0,0,0,2,0,10,0,0,0
1,2,1,1,0,0,1,2,0,3,0,1,4,2,1,1,2,1,0,2,0,0,0,0,0,0,0,0,0,0
Figure 4.7: Sample expression level output table.
4.5 Classification
4.5.1 Support Vector Machines
Support vector machines are supervised learning methods, based on statistical learning the-
ory, which are designed for classification and pattern recognition. SVM works by estimat-
ing a function called linear discriminant function that models the problem at hand [12; 62].
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The basic SVM is a two-class linear classifier that is based on a linear discriminant function
[4]. SVM could also be modeled as a non-linear classifier with the use of different kernel
functions. We examine both linear SVM and non-linear SVM in our approach. We have
tried various functions such as polynomial of degrees 2 and 3, radial basis, and sigmoid
function as kernels.
In essence, SVM maps the input samples to a higher dimension feature space, and tries
to find a hyperplane that separates the classes with the largest margin possible in the new
space. In case that the problem is not linearly separable, SVM, based on the idea of the
soft-margin, chooses a plane that separates the samples as clearly as possible.
In the present study, we used Weka with libSVM as well as libSVM implementation
in MATLAB for our SVM implementation. Both of these software packages are freely
available at their web sites [10; 21].
4.5.2 K-fold Cross-validation
In k-fold Cross-validation, the dataset is divided into k equal subsets. Each time, one of the
k subsets is chosen as the prediction set and the other k− 1 sets are used as training sets.
The average of the k accuracy rates is the cross-validation accuracy rate. The accuracy rate
is calculated by dividing the number of samples that has been classified correctly by the
total number of samples. We have used k-fold cross-validation as a validation technique for
our study in which we randomly divide our dataset into 10 subsets of equal sizes to perform
classification.
Part III
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Chapter 5
Results and Discussion
In this chapter, we present our results on steps that we take starting from finding splice
junctions from raw reads, to filtering them, selecting junctions as biomarkers, and finally
using them as features for the classification step.
5.1 Experimental Results
5.1.1 Reads
Our dataset contains 667,748,180 reads in total, with an average of 24,597,860 reads for
cancer samples and 17,579,096 for benign samples. This difference in number of reads
could be explained by different levels of expression between cancer and benign samples.
Figures 5.1 and 5.2 show the number of reads per sample for benign and cancer-diagnosed
groups.
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Figure 5.1: Number of reads among benign samples.
Figure 5.2: Number of reads among cancer samples.
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5.1.2 Splice Junctions
We obtained a total of 3,272,686 splice junctions from 30 samples using PASSion across
all chromosomes. Total number of junctions per sample is shown in Figure 5.3. In this
figure, the number of reads and number of junctions have been plotted against two different
axes. The number of junctions is represented by bars, while the number of reads is shown
by a dashed line. Figures 5.4 and 5.5 show the number of junctions found per sample for
the benign and cancer samples respectively. The Pearson correlation coefficient of 0.97
between the number of reads and the number of junctions found per sample indicates a
strong relationship between them.
Processing this data by PASSion took an estimated time of 2,200 CPU hours using two
2.26GHz Intel Xeon CPUs server running Ubuntu 10.04. While it is possible to run as many
threads as required using PASSion concurrently, due to the high memory consumption of
each thread, that is near 9GB, it was not possible for us to run more than 5 threads at a time
considering our server’s 48GB memory capacity.
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Figure 5.3: Number of reads and found junctions among all samples.
The average numbers of junctions found were 116,267 and 94,734 for cancer-diagnosed
samples and benign samples respectively. The higher number of junctions for cancer-
diagnosed samples indicates that higher levels of expression has lead to more splicing and
hence higher number of junctions. This result regarding splice junctions, follows the same
pattern as that observed by Kannan et al. [27], who studied this dataset previously, stating
that paired chimeric reads are shown to happen more frequently in cancer samples than in
benign samples.
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Figure 5.4: Number of junctions among benign samples.
Figure 5.5: Number of junctions among cancer samples.
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5.1.3 Junction Lengths
We calculated the length of the junctions across different samples and groups, and also
across different chromosomes. As can be seen in Figure 5.6, there is no significant differ-
ence between the lengths of junctions across different chromosomes. The minimum length
of junctions for all chromosomes is between 19 to 21 bp and the maximum length falls
between 391,653 to 409,637 bp. However, after analyzing the average lengths of junc-
tions across different samples, shown in Figure 5.7, it can be seen that the average length
of junctions in samples is affected by the number of reads for each junction and subse-
quently number of found junctions. In this figure, samples belonging to the benign group
are highlighted with a light color.
Figure 5.6: Average length of junctions across different chromosomes.
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Figure 5.7: Average length of junctions across different samples.
5.1.4 Filtering
We merged and combined junctions from our population of 30 samples to find a set of dis-
tinct junctions to be used as features for prediction of prostate cancer. After this step, we
applied our 2-D peak finding algorithm to remove dubious junctions. Figure 5.8 shows the
number of junctions before and after the filtering process. As expected, most junctions have
been found in Chromosome 1, which is the largest chromosome in the Human genome [52],
and the least number of junctions has been observed in Y chromosome. Our filtering mech-
anism reduced the number of junctions by 6 to 8 percent by removing erroneous junctions
by selecting 2 bp as our margin of error for the filtering process. Selecting a larger number
for the margin leads to larger cuts in the number of junctions. Table A.1 contains full list of
numbers of junctions before and after the filtering process for all chromosomes. We found
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469,133 distinct junctions in total across all chromosomes using 2bp as margin.
Figure 5.8: Number of junctions for each chromosome before and after filtering (margin=
2bp).
5.1.5 Scored Junctions
We calculated the frequency of junctions on different samples for each chromosome sepa-
rately. Using our scoring scheme that has been previously described in Section 4.4.1, we
score each junction using a number between −20 and 20, based on the number and class
of the samples which the junction belongs to. We acquired 323,097 junctions with score
greater than or equal to 1, and 146,036 junctions with a score lower than 1.
The histogram of junction scores for the first chromosome is shown in Figure 5.9. There
are two main peaks seen in the histogram, these peaks happen at the scores of 1 and −2.
This shows that the majority of junctions have been observed in only one sample. Each
junction that has happened in a single cancer sample scores 1 and each junction from the
benign group scores −2.
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The local minima seen at score −1 is explained mostly by the junctions that have oc-
curred at one sample belonging to cancer group and one sample from the normal group.
Figures 5.9, 5.10, 5.11, show the histograms for chromosomes 1, 14 and Y. It can be ob-
served from these figures that the shape of the histogram is almost identical across all these
three chromosomes. The same pattern happens among all other chromosomes as well. A
sharp peak is observed across all chromosomes at score 1.
Figure 5.9: Histogram of junction scores for Chromosome 1.
Figure 5.10: Histogram of junction scores for Chromosome 14.
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Figure 5.11: Histogram of junction scores for Chromosome Y.
5.1.6 Junction Selection
In order to select the junctions that better differentiate cancer group versus the benign group,
we designated an upper bound and a lower bound cutoff value for our feature selection. This
means that only junctions with scores more than the upper bound or with scores less than the
lower bound will be considered in our junction selection process, implying that junctions
that have happened more frequently for each class of samples have a higher chance to be
selected as our features. This process would make our classification meaningful and also
feasible given the vast number of junctions found from the dataset.
We applied classification on our scored junction dataset using SVM in order to predict
the class of the samples. We used a grid-search approach to find cross-validation accuracies
using SVM with different kernel functions. The grid-search approach enabled us to try a
wide range of different feature sets, based on different upper and lower bounds, for our
classification. The included kernels are: linear, radial basis, sigmoid and polynomial of
degrees 2 and 3.
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A range of 5 to 20 and −13 to −5, for upper and lower bounds respectively, have been
selected as our grid search range. Junctions with scores ranging from −5 to 5 have been
discarded altogether due to their insignificance in prediction and because of being at large
numbers. The lower bound limit stops at −13, as there was no junction with a score less
than that value. Table 5.1 shows different number of junctions selected based on different
upper and lower bounds.
-13 -12 -11 -10 -9 -8 -7 -6 -5
5 23,354 23,357 23,362 23,367 23,407 23,472 23,691 24,117 25,135
6 14,816 14,819 14,824 14,829 14,869 14,934 15,153 15,579 16,597
7 9,150 9,153 9,158 9,163 9,203 9,268 9,487 9,913 10,931
8 5,394 5,397 5,402 5,407 5,447 5,512 5,731 6,157 7,175
9 3,039 3,042 3,047 3,052 3,092 3,157 3,376 3,802 4,820
10 1,640 1,643 1,648 1,653 1,693 1,758 1,977 2,403 3,421
11 828 831 836 841 881 946 1,165 1,591 2,609
12 409 412 417 422 462 527 746 1,172 2,190
13 172 175 180 185 225 290 509 935 1,953
14 79 82 87 92 132 197 416 842 1,860
15 34 37 42 47 87 152 371 797 1,815
16 12 15 20 25 65 130 349 775 1,793
17 4 7 12 17 57 122 341 767 1,785
18 1 4 9 14 54 119 338 764 1,782
19 1 4 9 14 54 119 338 764 1,782
20 1 4 9 14 54 119 338 764 1,782
Table 5.1: Number of junctions used as features in the classification based on the scores.
The junctions considered for grid search, and consequently being in the feature set, are
shown with a lighter color in comparison to all junctions for Chromosome 1 in Figure 5.9.
In each run, a different set of features was used as the input for our classification module.
As shown in Figure 5.12, we achieved the best results using linear SVM. Table 5.2 shows
the acquired accuracy rates based on the upper and lower bounds of our algorithm. The
accuracy score in a square ranging from pairs of (−13,10) to (−10,14), in addition to
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other pairs close to the square such as (15,−9) was 100%, which is shown by a light shade
in the figure. Darker shades on the right side of the figure shows the areas that the accuracy
falls under 80%. This trend is observable also in Figures 5.13 and 5.14, which represents
our classification results using polynomial and RBF kernels.
We report our results with fixed SVM parameters with values of ε = 0.001, γ = 1, as
they proved to be the best in our runs. 100% 10-fold cross validation accuracy was gained
using linear SVM with as low as 12 junctions with all being positives scores, meaning that
they were more frequent in cancer samples.
Figure 5.12: Accuracy of linear SVM classification.
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Figure 5.13: Accuracy of SVM with polynomial kernel (degree 2) classification.
Figure 5.14: Accuracy of SVM with RBF kernel classification.
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-13 -12 -11 -10 -9 -8 -7 -6 -5
5 86.66 86.66 86.66 86.66 86.66 83.33 83.33 83.33 83.33
6 86.66 86.66 86.66 86.66 86.66 86.66 90.00 90.00 90.00
7 100.00 100.00 100.00 100.00 100.00 93.33 93.33 90.00 90.00
8 96.66 96.66 96.66 96.66 96.66 96.66 96.66 93.33 96.66
9 96.66 96.66 96.66 96.66 96.66 96.66 96.66 96.66 96.66
10 100.00 100.00 100.00 100.00 100.00 96.66 96.66 96.66 96.66
11 100.00 100.00 100.00 100.00 100.00 96.66 96.66 96.66 96.66
12 100.00 100.00 100.00 100.00 100.00 96.66 96.66 96.66 96.66
13 100.00 100.00 100.00 100.00 96.66 96.66 96.66 100.00 96.66
14 100.00 100.00 100.00 100.00 96.66 96.66 96.66 93.33 86.66
15 96.66 100.00 100.00 100.00 100.00 100.00 83.33 90.00 76.66
16 100.00 100.00 96.66 96.66 86.66 80.00 73.33 70.00 70.00
17 90.00 96.66 90.00 86.66 66.66 73.33 63.33 63.33 66.66
18 63.33 70.00 93.33 76.66 63.33 70.00 63.33 63.33 66.66
19 63.33 70.00 93.33 76.66 63.33 70.00 63.33 63.33 66.66
20 63.33 70.00 93.33 76.66 63.33 70.00 63.33 63.33 66.66
Table 5.2: Accuracy rates for linear SVM related to different scores.
5.1.7 Biological Analysis
To biologically analyze the results of our junction selection model, we focused on the 12
specific junctions belonging to the cancer-diagnosed group that we found using our scor-
ing scheme and led us to 100% classification accuracy. We used BioMart [28] to find
the corresponding gene for each of these junctions. In the next step, we used the Human
Protein Atlas [60] to study previous annotations of each of these genes and their relation-
ship prostate cancer. As shown in Table 5.3, cancer tissue staining was estimated at four
different levels, including strong, moderate, weak, and negative. Based on this resource,
these estimated numbers represent the percentage of samples that have been detected with
prostate cancer antibody for each gene. The last column of this table, Normal Tissue Stain-
ing (NTS), represents the level of staining for that particular gene under normal conditions.
We were then able to find cancer-staining information for 8 out of 12 studied genes. We
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left the table cells empty for the genes that we could not find in the Human Protein Atlas or
their impacts on various cancers were still under study.
Gene Str. Mod. Weak Neg. Junction Start Junction End Score Chr. NTS
SRBD1 0 14 45 41 45812911 45826586 17 2 Medium
CRYBG3 0 18 9 73 97619328 97631010 18 3 Negative
ATP8A1 5 86 5 4 42454074 42457312 17 4 Medium
TRAPPC13 64957973 64960060 17 5
FAM135A 0 46 25 29 71185250 71185364 17 6 Medium
POLR2J4 44056121 44058659 18 7
PDE3B 0 81 19 0 14810786 14825488 17 11 Medium
XPOT 0 0 64 36 64811891 64812652 17 12 Weak
LEMD3 0 18 55 27 65634865 65637166 17 12 Weak
AC004696.2 56989748 57005530 18 19
PLCB4 9351940 9352948 17 20
CA5B 27 73 0 0 15792518 15793367 17 X Weak
Table 5.3: Relationship of the genes containing selected features with prostate cancer.
5.2 Discussion
Based on the results of our study, we noticed that splice junctions happened more frequently
in the cancer-diagnosed group compared to the normal group. Kannan et al. [27] also claim
that based on their experiment, there are more chimeric RNAs in cancer than in benign
samples. They state that this could be a sign of chimeric events as a result of cancer.
The fact that no junction with a score less than−13 has been found, implies the insignif-
icance of junctions that only occur in samples belonging to benign tissues. The number of
junctions observed with a score less than −10 is only 13. In other words, in more than
460,000 junctions across all chromosomes, only 13 junctions have been found exclusively
in more than half of the benign sample population. The corresponding number of junctions
of the cancer group, with a score over 10, is 1,640 junctions.
This observation matches the fact that we were able to reach 100% accuracy using only
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junctions with positive scores, which we could not reach with negative scoring junctions.
It also can be seen that in all versions of the SVM classification that we tried, depicted in
Figures 5.12, 5.13, and 5.14, reducing the number of junctions with positive scores sig-
nificantly reduces the accuracy of our classification. This effect is not significant for the
opposite, meaning that accuracy of classification is not impacted heavily by reducing junc-
tions from normal group in the feature set.
By observing the histograms for scored junctions across all chromosomes, we were
unable to notice any significance for any chromosome. We also observed that linear clas-
sification leads to the best prediction results. Among other kernels, polynomial of degree
2 performed better than all other kernels including polynomial of degree 3. Also, sigmoid
and radial basis function kernels performed the worst among all the classifiers. This could
be due to overfitting in higher dimensions, indicating the linear nature of the problem [18].
We were able to spot a junction from gene CA5B in the X chromosome with a score
of 17. According to the Human Protein Atlas project, this gene has 27% strong and 73%
moderate staining property. This detection is significant as the aforementioned gene has
a weak staining property for normal samples. This could hint at further studies towards
splicing variants regarding this specific part of the gene. Also regarding the 8 genes that we
found information regarding their relationship with prostate cancer, they were 42% stained
moderately on average for prostate cancer. This fact supports our observation of higher
expression levels in prostate cancer samples for higher scoring junctions in our study.
Part IV
Conclusion
78
Chapter 6
Conclusions
In this research, our goal was to exploit the paired-end information of RNA-Seq reads to
extract biological meaning across a low population of samples. The sheer amount of data
in our dataset added a new level of complexity to the RNA-seq experiments. Another
challenge that we faced was differential detection of junctions across all samples in the
population.
Although the effects of alternative splicing on prostate cancer has been previously stud-
ied [20; 40; 57; 9], and Ren et al. [47] studied prostate cancer in the Chinese population
using alternative splicing on RNA-Seq data, we developed a novel model to apply machine
learning methods on RNA-Seq dataset to select junctions as features and classified prostate
cancer samples.
After studying current methods available for splice junction discovery, we selected PAS-
Sion to detect splice junctions for each individual sample. We designed and developed an
algorithm to combine and merge these individual results and used an scoring scheme to
select our junctions as biomarkers and consequently use them as features for our prediction
module. We tried support vector machines with different kernels and on different sets of
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features. A 100% 10-fold cross-validation accuracy has been achieved using linear SVM
for different sets of junctions as features. Finally, we did research on the smallest set of
junctions to compare with the previous findings regarding to prostate cancer on the genes
that those junctions were belonging to. We found out that at least in one of the genes, there
is an indication of significant relation to prostate cancer.
6.1 Contributions
• Design of a model for differential splice junction detection on prostate cancer data on
large scale.
• Developing a filtering and scoring model as a feature selection mechanism leading to
introducing junctions as biomarkers.
• Design of a machine learning based model for prediction of prostate cancer based on
the selected features.
6.2 Future Work
Although we have used number of supporting reads for each junction as part of our features
for the classification process, further analysis is needed in order to discover the probable
effect of using expression level measurements in the feature selection process. Combining
expression levels with our scoring algorithm might lead to more accurate results. Also
combining different known feature selection algorithms could improve the results of our
study.
Further studies regarding more accurate mapping of reads to the reference genome,
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which will lead to more accurate splice junctions could lead to better accuracies in our study.
Specifically, exploiting quality information of the reads stored in FASTQ format should
enable PASSion to find more precise expression level measurements and more accurate
junction positions.
Conducting pathway analysis could lead to a deeper biological insight into the result of
the junction selection process, as well as the biological processes associated with prostate
cancer.
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Number of chromosome Junctions after the filtering Junctions by PASSion
1 37309 40184
2 25718 27683
3 21779 23512
4 13537 14524
5 15896 17111
6 17841 19275
7 18718 20068
8 12092 13047
9 15967 17257
10 14789 15972
11 20453 22120
12 19674 21228
13 6315 6795
14 11970 12902
15 13165 14173
16 18150 19669
17 23382 25247
18 5543 5959
19 26088 28128
20 9891 10699
21 4763 5167
22 10605 11498
X 10330 11080
Y 666 710
Table A.1: Number of splice junctions for each chromosome before and after the filtering
process (Margin = 2).
Appendix B
Guide for Running the Software Tools
B.1 Running PASSion
For setting up the respective modules, the following settings should be applied:
• SRA-Toolkit usage: $fastq-dump --split-3 read.sra
• SMALT usage: $smalt index -k 13 -s 6 refindex reference.fa
• SAMTools: Latest version of samtools installed form ubuntu packages
– usage: $samtools faidx reference.fa
• PASSion ver 1.2.1 has been installed.
– PASSion usage: $passion.pl -s 150 -r read1.fq -f read2.fq
-R reference.fa -I refindex -o passion output
85
APPENDIX B. GUIDE FOR RUNNING THE SOFTWARE TOOLS 86
B.2 Junction Dataset
• Dataset of raw junctions is available in BED and DETAIL format upon request.
B.3 JunctionResolver
• JRE 1.7 should be installed to run this package.
• Readme file is provided with the package as a guide for installation and runnning.
B.4 2-D peak finding and Junction Selection
• MATLAB installation is needed to run modules developed in MATLAB language.
• Full documentation is provided in Readme file.
Bibliography
[1] Bruce Alberts, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and
Peter Walter. Molecular biology of the cell. Garland, 4th edition, 2002. ISBN
0815332181.
[2] Adam Ameur, Anna Wetterbom, Lars Feuk, and Ulf Gyllensten. Global and unbi-
ased detection of splice junctions from RNA-seq data. Genome biology, 11(3):R34,
January 2010. ISSN 1465-6914. doi: 10.1186/gb-2010-11-3-r34.
[3] Kin Fai Au, Hui Jiang, Lan Lin, Yi Xing, and Wing Hung Wong. Detection of splice
junctions from paired-end RNA-seq data by SpliceMap. Nucleic acids research, 38
(14):4570–8, August 2010. ISSN 1362-4962. doi: 10.1093/nar/gkq211.
[4] Asa Ben-Hur and Jason Weston. A user’s guide to support vector machines. Methods
in molecular biology (Clifton, N.J.), 609:223–39, January 2010. ISSN 1940-6029.
doi: 10.1007/978-1-60327-241-4 13.
[5] Brigitta M N Brinkman. Splice variants as cancer biomarkers. Clinical biochemistry,
37(7):584–94, July 2004. ISSN 0009-9120. doi: 10.1016/j.clinbiochem.2004.05.015.
[6] UCSC Genome Browser. UCSC genome browser - FAQ: Data file formats, 2013.
URL http://genome.ucsc.edu/FAQ/FAQformat.html.
87
BIBLIOGRAPHY 88
[7] Douglas W Bryant, Rongkun Shen, Henry D Priest, Weng-Keen Wong, and Todd C
Mockler. Supersplat–spliced RNA-seq alignment. Bioinformatics (Oxford, England),
26(12):1500–5, June 2010. ISSN 1367-4811. doi: 10.1093/bioinformatics/btq206.
[8] Paul D Burns. TrueSight-ES: Machine learning approach to detecting splice junctions
in RNA-Seq data. In Plant and Animal Genome XXI Conference. Plant and Animal
Genome, 2013.
[9] Russ P Carstens, James V Eaton, Hannah R Krigman, Philip J Walther, Mariano A
Garcia-Blanco, et al. Alternative splicing of fibroblast growth factor receptor 2 (fgf-
r2) in human prostate cancer. Oncogene, 15(25):3059, 1997.
[10] Chih-Chung Chang and Chih-Jen Lin. LIBSVM: A library for support vector ma-
chines. ACM Transactions on Intelligent Systems and Technology, 2:27:1–27:27,
2011. Software available at http://www.csie.ntu.edu.tw/˜cjlin/libsvm.
[11] Genome Reference Consortium. Genome reference consortium human build 37 patch
release 10 (grch37.p10), 2012. URL http://www.ncbi.nlm.nih.gov/assembly/
GCF_000001405.22/.
[12] Corinna Cortes and Vladimir Vapnik. Support-vector networks. Machine learning,
20(3):273–297, 1995.
[13] Fabio De Bona, Stephan Ossowski, Korbinian Schneeberger, and Gunnar Ra¨tsch. Op-
timal spliced alignments of short sequence reads. Bioinformatics (Oxford, England),
24(16):i174–80, August 2008. ISSN 1367-4811. doi: 10.1093/bioinformatics/btn300.
[14] Michelle T Dimon, Katherine Sorber, and Joseph L DeRisi. HMMSplicer: A tool
for efficient and sensitive discovery of known and novel splice junctions in RNA-Seq
BIBLIOGRAPHY 89
data. PloS one, 5(11):e13875, January 2010. ISSN 1932-6203. doi: 10.1371/journal.
pone.0013875.
[15] Huijuan Feng, Zhiyi Qin, and Xuegong Zhang. Opportunities and methods for study-
ing alternative splicing in cancer with RNA-Seq. Cancer letters, November 2012.
ISSN 1872-7980. doi: 10.1016/j.canlet.2012.11.010.
[16] Sergei a Filichkin, Henry D Priest, Scott a Givan, Rongkun Shen, Douglas W Bryant,
Samuel E Fox, Weng-Keen Wong, and Todd C Mockler. Genome-wide mapping of
alternative splicing in Arabidopsis thaliana. Genome research, 20(1):45–58, January
2010. ISSN 1549-5469. doi: 10.1101/gr.093302.109.
[17] Jessyka Fortin, Anne-Marie Moisan, Martine Dumont, Gilles Leblanc, Yvan Labrie,
Francine Durocher, Paul Bessette, Peter Bridge, Jocelyne Chiquette, Rachel Lafram-
boise, Jean Le´pine, Bernard Lespe´rance, Roxanne Pichette, Marie Plante, Louise
Provencher, Patricia Voyer, and Jacques Simard. A new alternative splice variant of
BRCA1 containing an additional in-frame exon. Biochimica et biophysica acta, 1731
(1):57–65, October 2005. ISSN 0006-3002. doi: 10.1016/j.bbaexp.2005.08.011.
[18] Tobias Glasmachers and Christian Igel. Maximum likelihood model selection for 1-
norm soft margin SVMs with multiple parameters. Pattern Analysis and Machine
Intelligence, IEEE Transactions on, 32(8):1522–1528, 2010.
[19] Patrick Goymer. Transcriptomics: There’s nothing abnormal about chimeric RNA.
Nature Reviews Genetics, 9:734, 2008. ISSN 14710056. doi: 10.1038/nrg2459.
[20] Zhiyong Guo, Xi Yang, Feng Sun, Richeng Jiang, Douglas E Linn, Hege Chen,
Hegang Chen, Xiangtian Kong, Jonathan Melamed, Clifford G Tepper, et al. A novel
BIBLIOGRAPHY 90
androgen receptor splice variant is up-regulated during prostate cancer progression
and promotes androgen depletion–resistant growth. Cancer research, 69(6):2305–
2313, 2009.
[21] Mark Hall, Eibe Frank, Geoffrey Holmes, Bernhard Pfahringer, Peter Reutemann, and
Ian H Witten. The WEKA data mining software: an update. SIGKDD Explorations,
11:10–18, 2009. ISSN 19310145. doi: 10.1145/1656274.1656278.
[22] Neil Hall. Advanced sequencing technologies and their wider impact in microbiology.
The Journal of experimental biology, 210(Pt 9):1518–25, May 2007. ISSN 00220949.
doi: 10.1242/jeb.001370.
[23] Songbo Huang, Jinbo Zhang, Ruiqiang Li, Wenqian Zhang, Zengquan He, Tak-Wah
Lam, Zhiyu Peng, and Siu-Ming Yiu. SOAPsplice: Genome-Wide ab initio Detection
of Splice Junctions from RNA-Seq Data. Frontiers in Genetics, 2(July):1–12, 2011.
ISSN 1664-8021. doi: 10.3389/fgene.2011.00046.
[24] Clyde A Hutchison. DNA sequencing: bench to bedside and beyond. Nucleic Acids
Research, 35:6227–6237, 2007. doi: 10.1093/nar/gkm688.
[25] Illumina Inc. Paired-end sequencing | achieve maximum coverage across the genome,
2010. URL http://www.illumina.com/technology/paired_end_sequencing_
assay.ilmn.
[26] Illumina Inc. Estimating sequencing coverage, October 2011. URL
http://res.illumina.com/documents/products/technotes/technote_
coverage_calculation.pdf.
BIBLIOGRAPHY 91
[27] Kalpana Kannan, Liguo Wang, Jianghua Wang, Michael M Ittmann, Wei Li, and Lais-
ing Yen. Recurrent chimeric RNAs enriched in human prostate cancer identified by
deep sequencing. Proceedings of the National Academy of Sciences of the United
States of America, 108(22):9172–7, May 2011. ISSN 1091-6490.
[28] Arek Kasprzyk. BioMart: driving a paradigm change in biological data management.
Database the journal of biological databases and curation, 2011:bar049, 2011. ISSN
17580463. doi: 10.1093/database/bar049.
[29] Ben Langmead, Cole Trapnell, Mihai Pop, and Steven L Salzberg. Ultrafast and
memory-efficient alignment of short DNA sequences to the human genome. Genome
biology, 10(3):R25, January 2009. ISSN 1465-6914. doi: 10.1186/gb-2009-10-3-r25.
[30] Heng Li and Richard Durbin. Fast and accurate short read alignment with Bur-
rowsWheeler transform. Bioinformatics, 25:1754–1760, 2009. doi: 10.1093/
bioinformatics/btp324.
[31] Ruiqiang Li, Yingrui Li, Karsten Kristiansen, and Jun Wang. SOAP: short oligonu-
cleotide alignment program. Bioinformatics (Oxford, England), 24(5):713–4, March
2008. ISSN 1367-4811. doi: 10.1093/bioinformatics/btn025.
[32] Ruiqiang Li, Chang Yu, Yingrui Li, Tak-Wah Lam, Siu-Ming Yiu, Karsten Kris-
tiansen, and Jun Wang. SOAP2: an improved ultrafast tool for short read alignment.
Bioinformatics, 25:1966–7, 2009. ISSN 13674811. doi: 10.1093/bioinformatics/
btp336.
[33] Yang Li, Jeremy Chien, David I Smith, and Jian Ma. FusionHunter: identifying fusion
transcripts in cancer using paired-end RNA-seq. Bioinformatics, 27:1708–1710, 2011.
BIBLIOGRAPHY 92
[34] Harvey Lodish, Arnold Berk, Chris A. Kaiser, Monty Krieger, Matthew P. Scott, An-
thony Bretscher, Hidde Ploegh, and Paul Matsudaira. Molecular Cell Biology (Lodish,
Molecular Cell Biology). W. H. Freeman, 6th edition, June 2007. ISBN 0716776014.
[35] Shao-Ke Lou, Jing-Woei Li, Hao Qin, Aldrin Yim, Leung-Yau Lo, Bing Ni, Kwong-
Sak Leung, Stephen Tsui, and Ting-Fung Chan. Detection of splicing events and
multiread locations from RNA-seq data based on a geometric-tail (GT) distribution
of intron length. BMC Bioinformatics, 12(Suppl 5):S2, 2011. ISSN 1471-2105. doi:
10.1186/1471-2105-12-S5-S2.
[36] Christopher A Maher, Chandan Kumar-Sinha, Xuhong Cao, Shanker Kalyana-
Sundaram, Bo Han, Xiaojun Jing, Lee Sam, Terrence Barrette, Nallasivam
Palanisamy, and Arul M Chinnaiyan. Transcriptome sequencing to detect gene fu-
sions in cancer. Nature, 458(7234):97–101, March 2009. ISSN 1476-4687. doi:
10.1038/nature07638.
[37] Christopher A Maher, Nallasivam Palanisamy, John C Brenner, Xuhong Cao, Shanker
Kalyana-Sundaram, Shujun Luo, Irina Khrebtukova, Terrence R Barrette, Cather-
ine Grasso, Jindan Yu, Robert J Lonigro, Gary Schroth, Chandan Kumar-Sinha, and
Arul M Chinnaiyan. Chimeric transcript discovery by paired-end transcriptome se-
quencing. PNAS, 106:12353–12358, 2009.
[38] Andrew McPherson, Fereydoun Hormozdiari, Abdalnasser Zayed, Ryan Giuliany,
Gavin Ha, Mark G F Sun, Malachi Griffith, Alireza Heravi Moussavi, Janine Senz,
Nataliya Melnyk, Marina Pacheco, Marco A Marra, Martin Hirst, Torsten O Nielsen,
S Cenk Sahinalp, David Huntsman, and Sohrab P Shah. deFuse: An Algorithm for
BIBLIOGRAPHY 93
Gene Fusion Discovery in Tumor RNA-Seq Data. PLoS Computational Biology, 7:
16, 2011. doi: 10.1371/journal.pcbi.1001138.
[39] Ali Mortazavi, Brian A Williams, Kenneth McCue, Lorian Schaeffer, and Barbara
Wold. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature
methods, 5(7):621–8, July 2008. ISSN 1548-7105. doi: 10.1038/nmeth.1226.
[40] Goutham Narla, Analisa DiFeo, Helen L Reeves, Daniel J Schaid, Jennifer Hirshfeld,
Eldad Hod, Amanda Katz, William B Isaacs, Scott Hebbring, Akira Komiya, et al.
A germline dna polymorphism enhances alternative splicing of the KLF6 tumor sup-
pressor gene and is associated with increased prostate cancer risk. Cancer research,
65(4):1213–1222, 2005.
[41] National Center for Biotechnology Information. SRA Handbook, 2010. URL http:
//www.ncbi.nlm.nih.gov/books/NBK47537/.
[42] Naoko Okumura, Hitomi Yoshida, Yasuko Kitagishi, Yuri Nishimura, and Satoru Mat-
suda. Alternative splicings on p53, BRCA1 and PTEN genes involved in breast can-
cer. Biochemical and biophysical research communications, 413(3):395–9, September
2011. ISSN 1090-2104. doi: 10.1016/j.bbrc.2011.08.098.
[43] Qun Pan, Ofer Shai, Leo J Lee, Brendan J Frey, and Benjamin J Blencowe. Deep
surveying of alternative splicing complexity in the human transcriptome by high-
throughput sequencing. Nature Genetics, 40:1413–5, 2008. ISSN 15461718. doi:
10.1038/ng.259.
[44] Dorothee Pflueger, Ste´phane Terry, Andrea Sboner, Lukas Habegger, Raquel Esgueva,
Pei-Chun Lin, Maria a Svensson, Naoki Kitabayashi, Benjamin J Moss, Theresa Y
BIBLIOGRAPHY 94
MacDonald, Xuhong Cao, Terrence Barrette, Ashutosh K Tewari, Mark S Chee,
Arul M Chinnaiyan, David S Rickman, Francesca Demichelis, Mark B Gerstein, and
Mark a Rubin. Discovery of non-ETS gene fusions in human prostate cancer us-
ing next-generation RNA sequencing. Genome research, 21(1):56–67, January 2011.
ISSN 1549-5469. doi: 10.1101/gr.110684.110.
[45] Dorothee Pflueger, Ste´phane Terry, Andrea Sboner, Lukas Habegger, Raquel Esgueva,
Pei-Chun Lin, Maria A Svensson, Naoki Kitabayashi, Benjamin J Moss, Theresa Y
MacDonald, Xuhong Cao, Terrence Barrette, Ashutosh K Tewari, Mark S Chee,
Arul M Chinnaiyan, David S Rickman, Francesca Demichelis, Mark B Gerstein,
and Mark A Rubin. Discovery of non-ETS gene fusions in human prostate cancer
using next-generation RNA sequencing. Genome Research, 21:56–67, 2011. doi:
10.1101/gr.110684.110.
[46] John R Prensner, Matthew K Iyer, O Alejandro Balbin, Saravana M Dhanasekaran,
Qi Cao, J Chad Brenner, Bharathi Laxman, Irfan A Asangani, Catherine S Grasso,
Hal D Kominsky, Xuhong Cao, Xiaojun Jing, Xiaoju Wang, Javed Siddiqui, John T
Wei, Daniel Robinson, Hari K Iyer, Nallasivam Palanisamy, Christopher A Maher,
and Arul M Chinnaiyan. Transcriptome sequencing across a prostate cancer cohort
identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature
Biotechnology, 29:742–749, 2011. doi: 10.1038/nbt.1914.
[47] Shancheng Ren, Zhiyu Peng, Jian-Hua Mao, Yongwei Yu, Changjun Yin, Xin Gao,
Zilian Cui, Jibin Zhang, Kang Yi, Weidong Xu, et al. RNA-Seq analysis of prostate
cancer in the Chinese population identifies recurrent gene fusions, cancer-associated
BIBLIOGRAPHY 95
long noncoding rnas and aberrant alternative splicings. Cell research, 22(5):806–821,
2012.
[48] Iman Rezaeian, Yifeng Li, Martin Crozier, Eran Andrechek, Alioune Ngom, Luis
Rueda, and Lisa Porter. Identifying informative genes for prediction of breast can-
cer subtypes. In Alioune Ngom, Enrico Formenti, Jin-Kao Hao, Xing-Ming Zhao,
and Twan Laarhoven, editors, Pattern Recognition in Bioinformatics, volume 7986
of Lecture Notes in Computer Science, pages 138–148. Springer Berlin Heidelberg,
2013. ISBN 978-3-642-39158-3.
[49] David S Rickman, Dorothee Pflueger, Benjamin Moss, Vanessa E VanDoren, Chen X
Chen, Alexandre de la Taille, Rainer Kuefer, Ashutosh K Tewari, Sunita R Setlur,
Francesca Demichelis, and Mark A Rubin. SLC45A3-ELK4 is a novel and fre-
quent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer
research, 69(7):2734–8, April 2009. ISSN 1538-7445. doi: 10.1158/0008-5472.
CAN-08-4926. URL http://www.ncbi.nlm.nih.gov/pubmed/19293179.
[50] Paul Ryvkin, Yuk Yee Leung, Li-San Wang, and Brian D Gregory. Invited: Multi-
class rna function classification using next-generation sequencing. In Computational
Advances in Bio and Medical Sciences (ICCABS), 2011 IEEE 1st International Con-
ference on, pages 10–10. IEEE, 2011.
[51] Anirban Sahu, Matthew K Iyer, and Arul M Chinnaiyan. Insights into Chinese prostate
cancer with RNA-seq. Cell research, 22(5):786–8, May 2012. ISSN 1748-7838. doi:
10.1038/cr.2012.50.
[52] Meena Kishore Sakharkar, Vincent T K Chow, and Pandjassarame Kangueane. Dis-
BIBLIOGRAPHY 96
tributions of exons and introns in the human genome. In silico biology, 4(4):387–93,
January 2004. ISSN 1386-6338.
[53] Bernhard Scho¨lkopf, K Tsuda, and J P Vert. Kernel Methods in Computational Biol-
ogy, volume 11. 2004.
[54] Rolf I Skotheim and Matthias Nees. Alternative splicing in cancer: noise, functional,
or systematic? The international journal of biochemistry & cell biology, 39(7-8):
1432–49, January 2007. ISSN 1357-2725. doi: 10.1016/j.biocel.2007.02.016.
[55] American Cancer Society. Cancer facts & figures 2013. Technical report, American
Cancer Society, Atlanta, GA, 2013.
[56] Kyle Strimbu and JA Tavel. What are biomarkers? Current opinion in HIV and AIDS,
5(6):463–466, 2010.
[57] Kasper Thorsen, Karina D Sørensen, Anne Sofie Brems-Eskildsen, Charlotte Modin,
Mette Gaustadnes, Anne-Mette K Hein, Mogens Kruhøffer, Søren Laurberg, Michael
Borre, Kai Wang, et al. Alternative splicing in colon, bladder, and prostate cancer
identified by exon array analysis. Molecular & Cellular Proteomics, 7(7):1214–1224,
2008.
[58] Cole Trapnell, Lior Pachter, and Steven L Salzberg. TopHat: discovering splice junc-
tions with RNA-Seq. Bioinformatics (Oxford, England), 25(9):1105–11, May 2009.
ISSN 1367-4811. doi: 10.1093/bioinformatics/btp120.
[59] Natalie A Twine, Karolina Janitz, Marc R Wilkins, and Michal Janitz. Whole tran-
scriptome sequencing reveals gene expression and splicing differences in brain regions
affected by alzheimer’s disease. PLoS One, 6(1):e16266, 2011.
BIBLIOGRAPHY 97
[60] Mathias Uhlen, Per Oksvold, Linn Fagerberg, Emma Lundberg, Kalle Jonasson, Mat-
tias Forsberg, Martin Zwahlen, Caroline Kampf, Kenneth Wester, Sophia Hober, Hen-
rik Wernerus, Lisa Bjo¨rling, and Fredrik Ponten. Towards a knowledge-based Human
Protein Atlas., 2010.
[61] user:Rgocs / Wikipedia: The Free Encyclopedia. RNA-Seq alignment with
intron-split short reads, 2009. URL http://en.wikipedia.org/wiki/File:
RNA-Seq-alignment.png.
[62] Vladimir N. Vapnik. Statistical learning theory. Wiley, 1998.
[63] Kai Wang, Darshan Singh, Zheng Zeng, Stephen J Coleman, Yan Huang, Gleb L
Savich, Xiaping He, Piotr Mieczkowski, Sara a Grimm, Charles M Perou, James N
MacLeod, Derek Y Chiang, Jan F Prins, and Jinze Liu. MapSplice: accurate mapping
of RNA-seq reads for splice junction discovery. Nucleic acids research, 38(18):e178,
October 2010. ISSN 1362-4962. doi: 10.1093/nar/gkq622.
[64] Weichen Wang, Zhiyi Qin, Zhixing Feng, Xi Wang, and Xuegong Zhang. Identifying
differentially spliced genes from two groups of RNA-seq samples. Gene, 518(1):
164–70, April 2013. ISSN 1879-0038. doi: 10.1016/j.gene.2012.11.045.
[65] Yu Wang, Igor V Tetko, Mark A Hall, Eibe Frank, Axel Facius, Klaus F X Mayer,
and Hans W Mewes. Gene selection from microarray data for cancer classification–a
machine learning approach. Computational Biology and Chemistry, 29:37–46, 2005.
[66] Zhong Wang, Mark Gerstein, and Michael Snyder. RNA-Seq: A revolutionary tool
for transcriptomics. Nature Reviews Genetics, 10(1):57–63, 2009.
BIBLIOGRAPHY 98
[67] Brian T Wilhelm and Josette-Rene´e Landry. RNA-Seq-quantitative measurement of
expression through massively parallel RNA-sequencing. Methods (San Diego, Calif.),
48(3):249–57, July 2009. ISSN 1095-9130. doi: 10.1016/j.ymeth.2009.03.016.
[68] Xiaolin Xu, KaiChang Zhu, Feng Liu, Yue Wang, JianGuo Shen, Jizhong Jin, Zhong
Wang, Lin Chen, Jiadong Li, and Min Xu. Identification of somatic mutations in
human prostate cancer by RNA-Seq. Gene, 519(2):343–7, May 2013. ISSN 1879-
0038. doi: 10.1016/j.gene.2013.01.046.
[69] Kevin Y Yip, Chao Cheng, and Mark Gerstein. Machine learning and genome anno-
tation: a match meant to be? Genome biology, 14(5):1–10, 2013.
[70] Yanju Zhang, Eric-Wubbo Lameijer, Peter a C ’t Hoen, Zemin Ning, P Eline Slag-
boom, and Kai Ye. PASSion: A pattern growth algorithm based pipeline for splice
junction detection in paired-end RNA-Seq data. Bioinformatics (Oxford, England),
28(4):479–486, January 2012. ISSN 1367-4811. doi: 10.1093/bioinformatics/btr712.
Vita Auctoris
Ahmad Tavakoli was born in 1987 in Mashhad, Iran. He graduate from the Ferdowsi Uni-
versity of Mashhad in 2009 with a Bachelor of Science degree in Computer Engineering.
He joined the University of Windsor’s School of Computer Science in September 2011 and
earned his Master of Science degree in September 2013.
99
